data_2eqh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2eqh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.671 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 1.3500000000000001 110.252 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 1.1899999999999999 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.34999999999999998 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.808 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.1100000000000001 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.7999999999999998 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 2.2799999999999998 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 1.1499999999999999 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 1.03 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.6600000000000001 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.808 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.96 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.999 -176.889 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 9' ' ' ALA . 13.0 t . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 120.485 0.183 . . . . 1.3500000000000001 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 1.1899999999999999 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.34999999999999998 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 1.1100000000000001 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.7999999999999998 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 2.2799999999999998 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 1.1499999999999999 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 1.03 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.6600000000000001 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.96 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.693 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8899999999999999 109.872 177.849 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.8 t . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.522 -0.548 . . . . 1.3500000000000001 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.693 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 1.1899999999999999 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.34999999999999998 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 1.1100000000000001 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.7999999999999998 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 2.2799999999999998 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 1.1499999999999999 109.516 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 1.03 113.716 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 18' ' ' ARG . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.6600000000000001 108.361 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.96 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8899999999999999 111.112 -176.882 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.559 HG11 ' H ' ' A' ' 9' ' ' ALA . 3.0 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 1.3500000000000001 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.559 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 1.1899999999999999 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.34999999999999998 112.397 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.948 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 1.1100000000000001 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.447 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.7999999999999998 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 2.2799999999999998 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 1.1499999999999999 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 1.03 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.6600000000000001 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.948 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.96 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8899999999999999 109.655 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 9' ' ' ALA . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 110.318 -0.253 . . . . 1.3500000000000001 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 1.1899999999999999 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.34999999999999998 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 1.1100000000000001 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.7999999999999998 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 2.2799999999999998 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 1.1499999999999999 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 1.03 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.6600000000000001 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.829 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.96 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.829 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8899999999999999 110.025 174.047 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.656 HG13 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.381 -0.229 . . . . 1.3500000000000001 110.381 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.656 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 1.1899999999999999 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.34999999999999998 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 1.1100000000000001 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.7999999999999998 110.093 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.811 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 2.2799999999999998 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 1.1499999999999999 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 1.03 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.6600000000000001 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.96 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8899999999999999 110.349 176.482 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.676 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.4 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.785 -0.45 . . . . 1.3500000000000001 109.785 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.676 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 1.1899999999999999 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.34999999999999998 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 1.1100000000000001 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.7999999999999998 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 2.2799999999999998 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 1.1499999999999999 110.496 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 1.03 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.6600000000000001 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.779 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.631 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.96 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8899999999999999 110.847 -174.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.674 HG11 ' H ' ' A' ' 9' ' ' ALA . 3.1 t . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.368 -0.604 . . . . 1.3500000000000001 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.674 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 1.1899999999999999 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.34999999999999998 111.971 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 1.1100000000000001 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.793 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.7999999999999998 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 2.2799999999999998 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 1.1499999999999999 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 1.03 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.6600000000000001 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.96 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8899999999999999 108.909 171.678 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.92 -0.4 . . . . 1.3500000000000001 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.463 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 1.1899999999999999 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.34999999999999998 111.644 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 1.1100000000000001 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.7999999999999998 110.17 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 2.2799999999999998 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 1.1499999999999999 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 1.03 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.6600000000000001 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.96 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8899999999999999 111.152 -175.413 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.729 0.3 . . . . 1.3500000000000001 110.452 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.663 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 1.1899999999999999 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.34999999999999998 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.503 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 1.1100000000000001 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.7999999999999998 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 2.2799999999999998 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 109.818 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 1.03 113.384 173.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.6600000000000001 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.263 -178.914 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 9' ' ' ALA . 17.2 t . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.878 -0.786 . . . . 1.3500000000000001 108.878 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.66 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 1.1100000000000001 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 2.2799999999999998 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 1.1499999999999999 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 1.03 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.6600000000000001 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.96 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8899999999999999 109.846 176.24 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t . . . . . 0 C--O 1.234 0.247 0 N-CA-C 110.042 -0.355 . . . . 1.3500000000000001 110.042 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.1899999999999999 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.34999999999999998 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 1.1100000000000001 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.5 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.7999999999999998 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 2.2799999999999998 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 1.1499999999999999 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 1.03 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.6600000000000001 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.96 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.648 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8899999999999999 110.445 176.669 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.704 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 1.3500000000000001 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 1.1899999999999999 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.34999999999999998 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.952 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 1.1100000000000001 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . 0.47 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.7999999999999998 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 2.2799999999999998 111.044 -174.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 1.1499999999999999 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 1.03 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.6600000000000001 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.952 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.96 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8899999999999999 111.754 -174.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 9' ' ' ALA . 3.6 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.857 -0.423 . . . . 1.3500000000000001 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 1.1899999999999999 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.34999999999999998 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 1.1100000000000001 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.7999999999999998 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.825 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 2.2799999999999998 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 1.1499999999999999 109.006 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 1.03 113.289 174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.6600000000000001 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.96 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8899999999999999 109.089 173.181 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 9' ' ' ALA . 5.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.458 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 1.1899999999999999 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.34999999999999998 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 1.1100000000000001 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.7999999999999998 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 1.098 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 2.2799999999999998 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 1.1499999999999999 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 1.03 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.6600000000000001 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 1.098 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.657 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.96 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8899999999999999 110.465 -176.224 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.458 0.171 . . . . 1.3500000000000001 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.1899999999999999 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.34999999999999998 111.906 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 1.1100000000000001 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.7999999999999998 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 2.2799999999999998 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 1.1499999999999999 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 1.03 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.6600000000000001 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.604 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.654 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.96 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.654 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8899999999999999 109.503 -176.92 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 9' ' ' ALA . 11.9 t . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 109.764 -0.458 . . . . 1.3500000000000001 109.764 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 1.1899999999999999 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.34999999999999998 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.7999999999999998 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 2.2799999999999998 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 1.1499999999999999 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 1.03 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.6600000000000001 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.96 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8899999999999999 110.036 177.992 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.399 0.143 . . . . 1.3500000000000001 111.152 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 1.1899999999999999 110.779 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.34999999999999998 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 1.1100000000000001 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.7999999999999998 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 2.2799999999999998 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 1.1499999999999999 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 1.03 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.6600000000000001 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.96 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8899999999999999 110.148 178.6 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.216 -0.29 . . . . 1.3500000000000001 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.446 ' N ' HG13 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 1.1899999999999999 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.34999999999999998 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.724 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 1.1100000000000001 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.7999999999999998 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 2.2799999999999998 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 1.03 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.6600000000000001 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.96 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.619 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8899999999999999 111.172 -176.6 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.732 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.619 0.247 . . . . 1.3500000000000001 111.214 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 1.1899999999999999 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.34999999999999998 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 1.1100000000000001 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.7999999999999998 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 2.2799999999999998 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 1.1499999999999999 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 1.03 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.6600000000000001 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.744 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.616 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8899999999999999 110.27 -174.281 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.409 ' H3 ' ' CD ' ' A' ' 1' ' ' GLU . 1.1 mp0 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.88 -0.415 . . . . 13.17 109.88 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.63 111.64 16.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 10.67 110.88 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.89 -0.07 18.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.385 0.612 . . . . 9.4900000000000002 109.82 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -91.37 25.21 2.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.614 -0.721 . . . . 8.0600000000000005 110.794 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.37 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 5.0800000000000001 112.505 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.09 -45.86 0.56 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.932 -0.651 . . . . 3.4300000000000002 111.808 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 11' ' ' TYR . 11.8 m -118.1 -159.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.548 -0.538 . . . . 1.6899999999999999 109.548 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.671 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t -62.04 162.71 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 1.3500000000000001 110.252 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 1.1899999999999999 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.34999999999999998 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.808 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 1.1100000000000001 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.413 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.7999999999999998 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 2.2799999999999998 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 1.1499999999999999 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 1.03 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.6600000000000001 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.808 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.96 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -14.86 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8899999999999999 110.999 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.607 -0.711 . . . . 3.8100000000000001 110.702 -177.198 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.91 0.386 . . . . 13.17 110.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.81 170.47 9.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.127 -0.488 . . . . 10.67 109.791 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -98.29 129.57 44.99 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.194 -0.669 . . . . 9.4900000000000002 109.194 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.412 ' OG ' ' HB2' ' A' ' 7' ' ' CYS . 6.7 t -67.91 -28.01 67.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.118 0.485 . . . . 8.0600000000000005 111.48 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.5 -104.24 3.09 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.749 -0.739 . . . . 5.0800000000000001 112.595 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.75 12.08 66.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.013 -0.613 . . . . 3.4300000000000002 112.41 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 21.6 m -108.11 151.35 26.0 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.966 -0.383 . . . . 1.6899999999999999 109.966 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG11 ' N ' ' A' ' 9' ' ' ALA . 13.0 t -63.27 167.74 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.359 -0.382 . . . . 1.3500000000000001 111.022 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 1.1899999999999999 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.34999999999999998 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.648 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 1.1100000000000001 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.7999999999999998 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 2.2799999999999998 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 1.1499999999999999 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 1.03 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.6600000000000001 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.693 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.96 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.693 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -107.07 -9.55 16.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8899999999999999 109.872 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.252 1.207 0 CA-C-N 115.397 -0.82 . . . . 3.8100000000000001 111.134 176.444 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.715 -0.476 . . . . 13.17 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -161.37 -36.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.119 0.485 . . . . 10.67 111.555 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -84.42 6.57 22.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 9.4900000000000002 111.558 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.27 55.87 1.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.144 0.497 . . . . 8.0600000000000005 111.388 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.44 55.99 4.49 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.996 -0.547 . . . . 5.0800000000000001 112.589 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.57 -48.9 0.95 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.983 -0.627 . . . . 3.4300000000000002 112.09 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.3 m -84.77 130.21 34.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.764 0.316 . . . . 1.6899999999999999 110.685 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.693 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.8 t -90.76 -172.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.548 . . . . 1.3500000000000001 109.522 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 1.1899999999999999 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.34999999999999998 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.552 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 1.1100000000000001 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.497 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.7999999999999998 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 2.2799999999999998 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 1.1499999999999999 109.516 174.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 1.03 113.716 171.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.412 ' HE ' ' HB3' ' A' ' 18' ' ' ARG . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.6600000000000001 108.361 173.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.614 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.587 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.96 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.587 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -88.04 47.19 1.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8899999999999999 111.112 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.219 -0.901 . . . . 3.8100000000000001 109.432 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.897 -0.409 . . . . 13.17 109.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.39 99.26 7.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.003 -0.369 . . . . 10.67 110.003 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -95.38 -21.37 18.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.647 0.737 . . . . 9.4900000000000002 110.015 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 p -67.58 123.45 20.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.627 -0.715 . . . . 8.0600000000000005 110.664 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.61 83.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.118 -0.563 . . . . 5.0800000000000001 112.107 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.93 88.05 0.2 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.225 -1.15 . . . . 3.4300000000000002 110.225 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.461 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 70.2 m -102.3 147.48 26.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.485 -0.358 . . . . 1.6899999999999999 111.227 -170.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.559 HG11 ' H ' ' A' ' 9' ' ' ALA . 3.0 t -81.29 175.2 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 1.3500000000000001 109.435 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.559 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 1.1899999999999999 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.34999999999999998 112.397 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.948 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 1.1100000000000001 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.447 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.7999999999999998 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 2.2799999999999998 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 1.1499999999999999 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 1.03 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.6600000000000001 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.948 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.704 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.96 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -93.72 -18.01 22.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8899999999999999 109.655 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.427 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.0 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.266 -0.873 . . . . 3.8100000000000001 110.738 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.677 0.275 . . . . 13.17 110.969 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.36 27.28 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.197 -0.456 . . . . 10.67 111.608 -171.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.22 -18.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.196 0.522 . . . . 9.4900000000000002 110.618 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -88.76 96.06 10.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.919 -0.582 . . . . 8.0600000000000005 111.281 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.93 112.61 0.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.825 -0.703 . . . . 5.0800000000000001 112.296 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.76 23.34 6.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.808 -0.711 . . . . 3.4300000000000002 112.214 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.421 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 97.4 m -93.31 177.15 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.682 0.277 . . . . 1.6899999999999999 110.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.432 HG11 ' N ' ' A' ' 9' ' ' ALA . 4.9 t -71.11 166.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.165 -0.471 . . . . 1.3500000000000001 110.318 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 1.1899999999999999 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.34999999999999998 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 1.1100000000000001 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.7999999999999998 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 2.2799999999999998 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 1.1499999999999999 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 1.03 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.6600000000000001 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.829 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.96 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.829 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -95.81 15.0 21.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8899999999999999 110.025 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.326 -0.852 . . . . 3.8100000000000001 109.648 -179.499 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.716 0.293 . . . . 13.17 110.465 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -79.92 -41.47 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 10.67 111.067 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -87.37 146.05 26.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 9.4900000000000002 110.483 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -90.5 162.43 15.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.901 -0.59 . . . . 8.0600000000000005 110.3 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.34 -172.33 33.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 5.0800000000000001 112.124 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.04 73.25 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.63 -0.588 . . . . 3.4300000000000002 111.63 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.1 m -88.6 126.2 35.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.823 0.344 . . . . 1.6899999999999999 110.724 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.656 HG13 ' H ' ' A' ' 9' ' ' ALA . 1.5 t -85.32 -171.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 1.3500000000000001 110.381 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.656 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 1.1899999999999999 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.34999999999999998 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 1.1100000000000001 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.7999999999999998 110.093 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.811 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 2.2799999999999998 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.433 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 1.1499999999999999 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 1.03 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.6600000000000001 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.96 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -116.26 100.32 7.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8899999999999999 110.349 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.5 -0.773 . . . . 3.8100000000000001 110.062 177.238 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.099 -0.334 . . . . 13.17 110.099 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -105.89 130.98 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.828 -0.434 . . . . 10.67 109.828 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -121.64 169.36 10.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.354 -0.385 . . . . 9.4900000000000002 111.006 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m -63.71 110.54 2.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.674 -0.694 . . . . 8.0600000000000005 111.723 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.98 28.67 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.679 -0.691 . . . . 5.0800000000000001 111.706 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.99 32.93 7.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.179 -0.534 . . . . 3.4300000000000002 111.96 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.8 m -85.05 108.09 17.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.154 0.502 . . . . 1.6899999999999999 110.821 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.676 HG11 ' H ' ' A' ' 9' ' ' ALA . 1.4 t -85.3 -166.13 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.338 -0.846 . . . . 1.3500000000000001 109.785 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.676 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 1.1899999999999999 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.34999999999999998 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.518 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 1.1100000000000001 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.7999999999999998 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.779 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 2.2799999999999998 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 1.1499999999999999 110.496 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 1.03 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.6600000000000001 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.779 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.631 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.96 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.631 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -115.58 13.69 16.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8899999999999999 110.847 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.521 -0.752 . . . . 3.8100000000000001 110.222 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.151 -0.315 . . . . 13.17 110.151 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -103.22 155.3 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.986 0.422 . . . . 10.67 111.299 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -106.46 109.35 21.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 9.4900000000000002 110.193 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 115.6 27.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.021 -0.536 . . . . 8.0600000000000005 110.296 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.02 153.67 6.51 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.921 -1.133 . . . . 5.0800000000000001 113.474 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.05 -34.53 5.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.279 -0.486 . . . . 3.4300000000000002 112.654 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.11 123.91 48.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.891 0.377 . . . . 1.6899999999999999 111.043 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.674 HG11 ' H ' ' A' ' 9' ' ' ALA . 3.1 t -82.19 -179.58 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.863 -0.608 . . . . 1.3500000000000001 109.368 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.674 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 1.1899999999999999 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.34999999999999998 111.971 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 1.1100000000000001 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.793 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.7999999999999998 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.753 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 2.2799999999999998 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 1.1499999999999999 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 1.03 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.6600000000000001 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.753 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.793 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.96 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t -106.05 -7.17 18.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8899999999999999 108.909 171.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.531 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 81.2 m-85 . . . . . 0 C--O 1.245 0.817 0 CA-C-N 114.443 -1.253 . . . . 3.8100000000000001 111.643 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.633 0.254 . . . . 13.17 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -99.66 129.22 45.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 10.67 110.162 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.22 143.68 48.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 9.4900000000000002 110.594 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -80.69 65.62 5.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.315 0.579 . . . . 8.0600000000000005 109.931 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.63 63.64 4.42 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.767 -0.651 . . . . 5.0800000000000001 112.641 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.93 -48.49 0.87 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.657 -0.577 . . . . 3.4300000000000002 111.657 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -121.62 143.23 49.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.197 -0.297 . . . . 1.6899999999999999 110.197 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t -70.76 169.49 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 1.3500000000000001 109.92 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.463 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 1.1899999999999999 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.34999999999999998 111.644 174.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.774 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 1.1100000000000001 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.7999999999999998 110.17 -178.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.527 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 2.2799999999999998 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 1.1499999999999999 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 1.03 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.6600000000000001 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.774 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.492 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.96 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.3 81.62 7.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8899999999999999 111.152 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.744 -0.662 . . . . 3.8100000000000001 109.468 177.205 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.111 0.481 . . . . 13.17 111.225 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -109.48 -20.9 12.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 10.67 109.755 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -78.65 130.15 35.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.689 . . . . 9.4900000000000002 110.044 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 t -72.84 117.58 14.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.063 0.459 . . . . 8.0600000000000005 110.219 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 174.71 13.6 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.553 -0.748 . . . . 5.0800000000000001 111.585 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.36 92.93 0.45 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.571 -0.823 . . . . 3.4300000000000002 111.865 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.8 m -105.88 130.12 53.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.058 0.456 . . . . 1.6899999999999999 110.643 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t -74.62 -178.99 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.564 -0.744 . . . . 1.3500000000000001 110.452 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.663 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 1.1899999999999999 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.34999999999999998 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.51 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 1.1100000000000001 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.7999999999999998 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.609 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 2.2799999999999998 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 1.1499999999999999 109.818 176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 1.03 113.384 173.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.6600000000000001 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.96 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.459 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -103.57 -1.64 27.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8899999999999999 110.263 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.072 -0.967 . . . . 3.8100000000000001 111.436 177.07 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.615 . . . . 13.17 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.67 -12.07 30.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.439 -0.346 . . . . 10.67 111.441 -170.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -91.6 81.8 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.949 0.404 . . . . 9.4900000000000002 110.204 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -81.55 -24.6 36.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.722 -0.672 . . . . 8.0600000000000005 111.111 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.7 -175.59 28.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.661 -0.781 . . . . 5.0800000000000001 111.734 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 -67.23 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 3.4300000000000002 112.096 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.69 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 34.5 m -136.9 -115.8 0.17 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.602 -0.518 . . . . 1.6899999999999999 109.602 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.444 HG11 ' N ' ' A' ' 9' ' ' ALA . 17.2 t -86.85 165.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 1.3500000000000001 108.878 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 1.1899999999999999 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.34999999999999998 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.66 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 1.1100000000000001 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.7999999999999998 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.699 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 2.2799999999999998 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 1.1499999999999999 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 1.03 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.6600000000000001 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.699 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.575 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.96 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p -88.57 78.7 7.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8899999999999999 109.846 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.0 p90 . . . . . 0 C--O 1.242 0.684 0 CA-C-N 115.509 -0.769 . . . . 3.8100000000000001 110.617 -178.666 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.442 0.163 . . . . 13.17 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -99.78 -74.08 0.61 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.707 0.289 . . . . 10.67 111.647 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -91.32 23.43 3.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 9.4900000000000002 111.031 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m -84.5 104.36 14.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 8.0600000000000005 110.972 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.96 -109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.628 -0.796 . . . . 5.0800000000000001 112.104 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.98 151.5 7.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.163 -0.541 . . . . 3.4300000000000002 112.352 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.5 m -140.98 146.36 37.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.784 0.326 . . . . 1.6899999999999999 110.61 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t -73.85 168.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.768 -0.651 . . . . 1.3500000000000001 110.042 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.1899999999999999 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.34999999999999998 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 1.1100000000000001 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.5 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.7999999999999998 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.483 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 2.2799999999999998 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 1.1499999999999999 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 1.03 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.6600000000000001 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.648 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.96 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.648 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -119.13 -18.65 8.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8899999999999999 110.445 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 117.958 -1.02 . . . . 3.8100000000000001 110.801 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.823 0.344 . . . . 13.17 110.742 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.3 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.018 0.437 . . . . 10.67 110.386 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -81.65 -23.4 36.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.923 -0.58 . . . . 9.4900000000000002 111.214 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -82.95 7.35 15.75 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.315 0.487 . . . . 8.0600000000000005 112.315 -173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.487 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -174.83 152.5 13.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.642 -1.266 . . . . 5.0800000000000001 112.934 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.15 37.64 1.31 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 109.882 -1.287 . . . . 3.4300000000000002 109.882 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -160.08 -157.69 0.58 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.586 -0.807 . . . . 1.6899999999999999 109.591 -172.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.704 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t -62.25 160.55 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 1.3500000000000001 110.69 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 1.1899999999999999 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.34999999999999998 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.952 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 1.1100000000000001 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . 0.47 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.7999999999999998 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.487 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 2.2799999999999998 111.044 -174.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 1.1499999999999999 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 1.03 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.6600000000000001 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.952 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.96 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p -86.79 91.18 8.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8899999999999999 111.754 -174.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.7 p90 . . . . . 0 C--O 1.244 0.798 0 CA-C-N 115.43 -0.805 . . . . 3.8100000000000001 109.261 174.618 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.471 0.177 . . . . 13.17 110.8 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.19 -53.92 6.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 10.67 110.606 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -104.04 126.07 50.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.804 0.335 . . . . 9.4900000000000002 110.179 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -64.11 113.8 3.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 8.0600000000000005 111.19 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -148.07 -178.85 23.57 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.908 -0.663 . . . . 5.0800000000000001 111.648 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.48 -34.38 5.62 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 3.4300000000000002 111.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.426 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 64.6 m -116.09 151.78 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.786 0.327 . . . . 1.6899999999999999 110.744 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG13 ' H ' ' A' ' 9' ' ' ALA . 3.6 t -82.49 172.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 1.3500000000000001 109.857 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.49 ' H ' HG13 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 1.1899999999999999 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.34999999999999998 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 1.1100000000000001 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.7999999999999998 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.825 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 2.2799999999999998 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 1.1499999999999999 109.006 173.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 1.03 113.289 174.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.6600000000000001 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.825 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.96 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.507 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t -118.25 88.53 2.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8899999999999999 109.089 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 p90 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.012 -0.994 . . . . 3.8100000000000001 110.936 -175.648 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.029 0.443 . . . . 13.17 110.432 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -95.58 83.85 3.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.469 -0.567 . . . . 10.67 109.469 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -124.02 136.62 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.099 -0.5 . . . . 9.4900000000000002 109.894 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.8 m -74.09 -16.3 61.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.128 -0.487 . . . . 8.0600000000000005 111.809 -175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.2 -122.6 6.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.697 -0.763 . . . . 5.0800000000000001 113.125 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.98 -11.18 85.8 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.358 -0.449 . . . . 3.4300000000000002 112.921 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.695 ' SG ' ' HB3' ' A' ' 13' ' ' ARG . 58.4 m -116.94 154.27 31.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.639 -0.504 . . . . 1.6899999999999999 109.639 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.458 HG11 ' N ' ' A' ' 9' ' ' ALA . 5.9 t -78.39 169.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.083 -0.34 . . . . 1.3500000000000001 110.083 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.458 ' N ' HG11 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 1.1899999999999999 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.34999999999999998 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.581 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 1.1100000000000001 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.7999999999999998 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 1.098 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 2.2799999999999998 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 1.1499999999999999 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 1.03 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.6600000000000001 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 1.098 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.657 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.96 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.657 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p -88.94 -31.59 18.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8899999999999999 110.465 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.778 -1.105 . . . . 3.8100000000000001 110.103 -174.543 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.083 0.468 . . . . 13.17 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -83.55 104.58 13.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.317 0.579 . . . . 10.67 110.021 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -79.4 -1.07 35.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.484 -0.78 . . . . 9.4900000000000002 111.18 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -71.15 -30.38 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.089 -0.505 . . . . 8.0600000000000005 110.019 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.93 126.88 1.29 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.091 -0.576 . . . . 5.0800000000000001 111.718 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.28 56.08 1.75 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 3.4300000000000002 112.486 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 15.8 m -139.58 159.34 42.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.897 0.379 . . . . 1.6899999999999999 110.603 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.45 163.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 1.3500000000000001 110.569 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 1.1899999999999999 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.34999999999999998 111.906 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 1.1100000000000001 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.7999999999999998 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 2.2799999999999998 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 1.1499999999999999 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 1.03 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.604 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.6600000000000001 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.604 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.654 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.96 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.654 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -107.12 -23.13 12.4 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8899999999999999 109.503 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 56.2 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 114.936 -1.029 . . . . 3.8100000000000001 111.02 174.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.867 -0.049 . . . . 13.17 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.58 -59.86 0.21 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.218 0.451 . . . . 10.67 112.218 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -107.61 14.07 26.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.28 0.474 . . . . 9.4900000000000002 112.28 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 t -77.07 -22.97 52.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.61 0.243 . . . . 8.0600000000000005 111.142 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.57 -140.99 3.25 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.771 -0.728 . . . . 5.0800000000000001 112.401 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.88 -35.03 1.96 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.842 -0.694 . . . . 3.4300000000000002 112.218 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.604 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 18.4 m -121.18 -160.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.428 . . . . 1.6899999999999999 110.639 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.407 HG13 ' N ' ' A' ' 9' ' ' ALA . 11.9 t -88.86 167.48 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.546 . . . . 1.3500000000000001 109.764 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 1.1899999999999999 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.34999999999999998 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.671 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 1.1100000000000001 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.7999999999999998 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 2.2799999999999998 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 1.1499999999999999 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 1.03 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.6600000000000001 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.645 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.96 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.671 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -98.93 94.08 6.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8899999999999999 110.036 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.297 -0.858 . . . . 3.8100000000000001 110.703 -178.331 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.988 -0.375 . . . . 13.17 109.988 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -96.67 -60.77 1.53 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.681 -0.489 . . . . 10.67 109.681 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -97.88 115.05 27.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 9.4900000000000002 109.907 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 p -90.37 -67.22 0.86 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.211 0.529 . . . . 8.0600000000000005 110.552 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.52 110.11 0.43 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.686 -0.688 . . . . 5.0800000000000001 111.928 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 -30.83 77.33 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.666 -0.778 . . . . 3.4300000000000002 112.325 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 10.1 m -142.52 162.05 36.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.659 0.266 . . . . 1.6899999999999999 110.542 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.8 t -71.63 168.55 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.755 -0.657 . . . . 1.3500000000000001 111.152 -176.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 1.1899999999999999 110.779 174.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.34999999999999998 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.635 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 1.1100000000000001 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.7999999999999998 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.662 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 2.2799999999999998 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 1.1499999999999999 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.597 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 1.03 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.6600000000000001 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.662 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.96 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -110.21 -7.79 14.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8899999999999999 110.148 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.372 -0.831 . . . . 3.8100000000000001 111.444 177.708 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.032 0.444 . . . . 13.17 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -101.15 103.98 15.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.431 . . . . 10.67 110.093 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -97.23 -25.44 15.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.063 0.458 . . . . 9.4900000000000002 110.776 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 t -81.56 13.4 3.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 8.0600000000000005 111.53 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.1 -24.94 65.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.719 -0.753 . . . . 5.0800000000000001 112.452 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.31 -174.68 46.53 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.159 -0.776 . . . . 3.4300000000000002 111.159 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 165.87 25.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.696 0.284 . . . . 1.6899999999999999 110.625 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.724 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t -73.72 165.51 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.27 -0.423 . . . . 1.3500000000000001 110.216 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.446 ' N ' HG13 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 1.1899999999999999 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.34999999999999998 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.724 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 1.1100000000000001 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.7999999999999998 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 2.2799999999999998 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 1.1499999999999999 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 1.03 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.6600000000000001 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.619 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.96 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.619 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t -97.11 97.94 9.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8899999999999999 111.172 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.686 -1.143 . . . . 3.8100000000000001 108.857 173.174 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 111.866 0.321 . . . . 13.17 111.866 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.94 152.97 23.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.797 -0.445 . . . . 10.67 109.797 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -125.7 -40.91 2.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.824 0.345 . . . . 9.4900000000000002 111.341 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 t -71.47 121.18 18.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.833 -0.347 . . . . 8.0600000000000005 110.811 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.31 85.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.027 -0.606 . . . . 5.0800000000000001 112.578 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.77 146.47 4.7 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.578 -0.82 . . . . 3.4300000000000002 112.446 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.24 -175.53 5.02 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.028 -0.36 . . . . 1.6899999999999999 110.028 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.732 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t -59.62 154.39 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.509 0.323 . . . . 1.3500000000000001 111.214 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 1.1899999999999999 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' HG11 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.34999999999999998 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.744 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 1.1100000000000001 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.7999999999999998 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.691 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 2.2799999999999998 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 1.1499999999999999 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 1.03 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.6600000000000001 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.744 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.628 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.616 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -125.21 21.51 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8899999999999999 110.27 -174.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 3.8100000000000001 110.879 178.331 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 0.81999999999999995 110.252 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 0.47999999999999998 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.28000000000000003 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.53000000000000003 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.1400000000000001 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 1.8999999999999999 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 0.41999999999999998 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.0499999999999998 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.3799999999999999 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8 110.999 -176.889 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 9' ' ' ALA . 13.0 t . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 120.485 0.183 . . . . 0.81999999999999995 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 0.47999999999999998 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.28000000000000003 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.655 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 0.53000000000000003 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.1400000000000001 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 1.8999999999999999 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 0.41999999999999998 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 0.67000000000000004 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.0499999999999998 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.711 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.3799999999999999 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8 109.872 177.849 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.8 t . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.522 -0.548 . . . . 0.81999999999999995 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 0.47999999999999998 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.28000000000000003 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 0.53000000000000003 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.1400000000000001 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 1.8999999999999999 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 0.41999999999999998 109.516 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 113.716 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.0499999999999998 108.361 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.3799999999999999 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8 111.112 -176.882 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.0 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 0.81999999999999995 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 0.47999999999999998 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.28000000000000003 112.397 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.931 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 0.53000000000000003 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.1400000000000001 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 1.8999999999999999 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 0.67000000000000004 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.0499999999999998 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.3799999999999999 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8 109.655 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 9' ' ' ALA . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 110.318 -0.253 . . . . 0.81999999999999995 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 0.47999999999999998 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.28000000000000003 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 0.53000000000000003 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.1400000000000001 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.782 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 1.8999999999999999 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 0.41999999999999998 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 0.67000000000000004 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.0499999999999998 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.839 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.3799999999999999 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.839 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8 110.025 174.047 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.381 -0.229 . . . . 0.81999999999999995 110.381 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 0.47999999999999998 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.28000000000000003 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 0.53000000000000003 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.1400000000000001 110.093 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 1.8999999999999999 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 0.41999999999999998 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 0.67000000000000004 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.0499999999999998 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.836 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.3799999999999999 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8 110.349 176.482 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.4 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.785 -0.45 . . . . 0.81999999999999995 109.785 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.47999999999999998 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.28000000000000003 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 0.53000000000000003 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.1400000000000001 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 1.8999999999999999 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 16' ' ' ASP . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 0.41999999999999998 110.496 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 0.67000000000000004 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.0499999999999998 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8 110.847 -174.547 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.1 t . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.368 -0.604 . . . . 0.81999999999999995 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.691 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 0.47999999999999998 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.28000000000000003 111.971 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 0.53000000000000003 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.807 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 1.8999999999999999 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 0.41999999999999998 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 0.67000000000000004 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.0499999999999998 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.807 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.3799999999999999 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8 108.909 171.678 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.92 -0.4 . . . . 0.81999999999999995 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 0.47999999999999998 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.28000000000000003 111.644 174.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 0.53000000000000003 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.17 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 1.8999999999999999 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 0.41999999999999998 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 0.67000000000000004 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.0499999999999998 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.3799999999999999 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8 111.152 -175.413 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.729 0.3 . . . . 0.81999999999999995 110.452 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.28000000000000003 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 0.53000000000000003 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.1400000000000001 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 1.8999999999999999 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 0.41999999999999998 109.818 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 0.67000000000000004 113.384 173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.0499999999999998 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.3799999999999999 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8 110.263 -178.914 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 17.2 t . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.878 -0.786 . . . . 0.81999999999999995 108.878 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 0.47999999999999998 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.28000000000000003 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.681 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.53000000000000003 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.1400000000000001 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 1.8999999999999999 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 0.41999999999999998 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 0.67000000000000004 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.0499999999999998 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.3799999999999999 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8 109.846 176.24 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t . . . . . 0 C--O 1.234 0.247 0 N-CA-C 110.042 -0.355 . . . . 0.81999999999999995 110.042 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.47999999999999998 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.28000000000000003 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 0.53000000000000003 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 1.8999999999999999 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 0.41999999999999998 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 0.67000000000000004 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.0499999999999998 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.3799999999999999 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8 110.445 176.669 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 0.81999999999999995 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 0.47999999999999998 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.28000000000000003 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.962 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 0.53000000000000003 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.1400000000000001 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 1.8999999999999999 111.044 -174.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 0.41999999999999998 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 0.67000000000000004 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.0499999999999998 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.3799999999999999 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8 111.754 -174.46 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.6 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.857 -0.423 . . . . 0.81999999999999995 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.47999999999999998 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.28000000000000003 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 0.53000000000000003 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.1400000000000001 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 1.8999999999999999 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 0.41999999999999998 109.006 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 0.67000000000000004 113.289 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.0499999999999998 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.3799999999999999 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8 109.089 173.181 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' ALA . 5.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 110.083 -0.34 . . . . 0.81999999999999995 110.083 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.47999999999999998 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.28000000000000003 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 0.53000000000000003 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.1400000000000001 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 1.119 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 1.8999999999999999 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 0.41999999999999998 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 0.67000000000000004 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.0499999999999998 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 1.119 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.3799999999999999 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8 110.465 -176.224 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.458 0.171 . . . . 0.81999999999999995 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 111.906 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 0.53000000000000003 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.1400000000000001 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 0.41999999999999998 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 0.67000000000000004 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.0499999999999998 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.3799999999999999 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.659 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8 109.503 -176.92 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.9 t . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 109.764 -0.458 . . . . 0.81999999999999995 109.764 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.28000000000000003 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 1.8999999999999999 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 0.41999999999999998 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 0.67000000000000004 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.0499999999999998 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.3799999999999999 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8 110.036 177.992 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 9' ' ' ALA . 2.8 t . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.399 0.143 . . . . 0.81999999999999995 111.152 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.402 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 0.47999999999999998 110.779 174.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.28000000000000003 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 0.53000000000000003 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.1400000000000001 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 0.41999999999999998 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 0.67000000000000004 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.0499999999999998 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.3799999999999999 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8 110.148 178.6 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.723 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.216 -0.29 . . . . 0.81999999999999995 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 0.47999999999999998 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.28000000000000003 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.723 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 0.53000000000000003 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.1400000000000001 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 1.8999999999999999 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 0.41999999999999998 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 0.67000000000000004 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.0499999999999998 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.632 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.3799999999999999 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8 111.172 -176.6 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.619 0.247 . . . . 0.81999999999999995 111.214 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 0.47999999999999998 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.28000000000000003 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 0.53000000000000003 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.1400000000000001 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 1.8999999999999999 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 0.41999999999999998 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 0.67000000000000004 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.0499999999999998 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.3799999999999999 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.625 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8 110.27 -174.281 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.88 -0.415 . . . . 13.17 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.63 111.64 16.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 10.300000000000001 110.88 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.89 -0.07 18.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.385 0.612 . . . . 8.9100000000000001 109.82 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -91.37 25.21 2.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.614 -0.721 . . . . 7.79 110.794 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.37 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 5.0199999999999996 112.505 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.09 -45.86 0.56 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.932 -0.651 . . . . 3.1600000000000001 111.808 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 11' ' ' TYR . 11.8 m -118.1 -159.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.548 -0.538 . . . . 1.51 109.548 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t -62.04 162.71 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 0.81999999999999995 110.252 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 0.47999999999999998 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.28000000000000003 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.53000000000000003 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.1400000000000001 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 1.8999999999999999 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 0.41999999999999998 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.0499999999999998 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.3799999999999999 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -14.86 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8 110.999 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.607 -0.711 . . . . 3.8100000000000001 110.702 -177.198 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.91 0.386 . . . . 13.17 110.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.81 170.47 9.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.127 -0.488 . . . . 10.300000000000001 109.791 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -98.29 129.57 44.99 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.194 -0.669 . . . . 8.9100000000000001 109.194 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 7' ' ' CYS . 6.7 t -67.91 -28.01 67.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.118 0.485 . . . . 7.79 111.48 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.5 -104.24 3.09 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.749 -0.739 . . . . 5.0199999999999996 112.595 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.75 12.08 66.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.013 -0.613 . . . . 3.1600000000000001 112.41 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 21.6 m -108.11 151.35 26.0 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.966 -0.383 . . . . 1.51 109.966 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 9' ' ' ALA . 13.0 t -63.27 167.74 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.359 -0.382 . . . . 0.81999999999999995 111.022 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 0.47999999999999998 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.28000000000000003 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.655 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 0.53000000000000003 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.1400000000000001 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 1.8999999999999999 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 0.41999999999999998 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 0.67000000000000004 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.0499999999999998 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.711 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.3799999999999999 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -107.07 -9.55 16.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8 109.872 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.252 1.207 0 CA-C-N 115.397 -0.82 . . . . 3.8100000000000001 111.134 176.444 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.715 -0.476 . . . . 13.17 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -161.37 -36.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.119 0.485 . . . . 10.300000000000001 111.555 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -84.42 6.57 22.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 8.9100000000000001 111.558 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.27 55.87 1.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.144 0.497 . . . . 7.79 111.388 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.44 55.99 4.49 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.996 -0.547 . . . . 5.0199999999999996 112.589 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.57 -48.9 0.95 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.983 -0.627 . . . . 3.1600000000000001 112.09 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.3 m -84.77 130.21 34.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.764 0.316 . . . . 1.51 110.685 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.8 t -90.76 -172.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.548 . . . . 0.81999999999999995 109.522 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 0.47999999999999998 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.28000000000000003 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 0.53000000000000003 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.1400000000000001 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 1.8999999999999999 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 0.41999999999999998 109.516 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 113.716 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.0499999999999998 108.361 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.3799999999999999 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -88.04 47.19 1.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8 111.112 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.219 -0.901 . . . . 3.8100000000000001 109.432 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.897 -0.409 . . . . 13.17 109.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.39 99.26 7.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.003 -0.369 . . . . 10.300000000000001 110.003 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -95.38 -21.37 18.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.647 0.737 . . . . 8.9100000000000001 110.015 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 p -67.58 123.45 20.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.627 -0.715 . . . . 7.79 110.664 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.61 83.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.118 -0.563 . . . . 5.0199999999999996 112.107 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.93 88.05 0.2 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.225 -1.15 . . . . 3.1600000000000001 110.225 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 70.2 m -102.3 147.48 26.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.485 -0.358 . . . . 1.51 111.227 -170.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.0 t -81.29 175.2 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 0.81999999999999995 109.435 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 0.47999999999999998 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.28000000000000003 112.397 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.931 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 0.53000000000000003 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.1400000000000001 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 1.8999999999999999 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 0.67000000000000004 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.0499999999999998 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.3799999999999999 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -93.72 -18.01 22.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8 109.655 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.0 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.266 -0.873 . . . . 3.8100000000000001 110.738 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.677 0.275 . . . . 13.17 110.969 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.36 27.28 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.197 -0.456 . . . . 10.300000000000001 111.608 -171.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.22 -18.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.196 0.522 . . . . 8.9100000000000001 110.618 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -88.76 96.06 10.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.919 -0.582 . . . . 7.79 111.281 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.93 112.61 0.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.825 -0.703 . . . . 5.0199999999999996 112.296 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.76 23.34 6.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.808 -0.711 . . . . 3.1600000000000001 112.214 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 97.4 m -93.31 177.15 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.682 0.277 . . . . 1.51 110.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 9' ' ' ALA . 4.9 t -71.11 166.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.165 -0.471 . . . . 0.81999999999999995 110.318 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 0.47999999999999998 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.28000000000000003 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 0.53000000000000003 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.1400000000000001 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.782 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 1.8999999999999999 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 0.41999999999999998 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 0.67000000000000004 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.0499999999999998 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.839 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.3799999999999999 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.839 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -95.81 15.0 21.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8 110.025 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.326 -0.852 . . . . 3.8100000000000001 109.648 -179.499 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.716 0.293 . . . . 13.17 110.465 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -79.92 -41.47 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 10.300000000000001 111.067 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -87.37 146.05 26.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 8.9100000000000001 110.483 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -90.5 162.43 15.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.901 -0.59 . . . . 7.79 110.3 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.34 -172.33 33.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 5.0199999999999996 112.124 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.04 73.25 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.63 -0.588 . . . . 3.1600000000000001 111.63 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.1 m -88.6 126.2 35.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.823 0.344 . . . . 1.51 110.724 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t -85.32 -171.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.81999999999999995 110.381 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 0.47999999999999998 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.28000000000000003 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 0.53000000000000003 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.1400000000000001 110.093 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 1.8999999999999999 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 0.41999999999999998 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 0.67000000000000004 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.0499999999999998 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.836 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.3799999999999999 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -116.26 100.32 7.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8 110.349 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.5 -0.773 . . . . 3.8100000000000001 110.062 177.238 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.099 -0.334 . . . . 13.17 110.099 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -105.89 130.98 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.828 -0.434 . . . . 10.300000000000001 109.828 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -121.64 169.36 10.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.354 -0.385 . . . . 8.9100000000000001 111.006 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m -63.71 110.54 2.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.674 -0.694 . . . . 7.79 111.723 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.98 28.67 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.679 -0.691 . . . . 5.0199999999999996 111.706 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.99 32.93 7.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.179 -0.534 . . . . 3.1600000000000001 111.96 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.8 m -85.05 108.09 17.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.154 0.502 . . . . 1.51 110.821 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.4 t -85.3 -166.13 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.338 -0.846 . . . . 0.81999999999999995 109.785 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.47999999999999998 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.28000000000000003 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 0.53000000000000003 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.1400000000000001 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 1.8999999999999999 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 16' ' ' ASP . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 0.41999999999999998 110.496 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 0.67000000000000004 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.0499999999999998 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -115.58 13.69 16.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8 110.847 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.521 -0.752 . . . . 3.8100000000000001 110.222 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.151 -0.315 . . . . 13.17 110.151 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -103.22 155.3 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.986 0.422 . . . . 10.300000000000001 111.299 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -106.46 109.35 21.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 8.9100000000000001 110.193 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 115.6 27.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.021 -0.536 . . . . 7.79 110.296 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.02 153.67 6.51 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.921 -1.133 . . . . 5.0199999999999996 113.474 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.05 -34.53 5.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.279 -0.486 . . . . 3.1600000000000001 112.654 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.11 123.91 48.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.891 0.377 . . . . 1.51 111.043 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.1 t -82.19 -179.58 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.863 -0.608 . . . . 0.81999999999999995 109.368 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.691 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 0.47999999999999998 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.28000000000000003 111.971 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 0.53000000000000003 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.807 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 1.8999999999999999 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 0.41999999999999998 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 0.67000000000000004 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.0499999999999998 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.807 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.3799999999999999 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t -106.05 -7.17 18.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8 108.909 171.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 81.2 m-85 . . . . . 0 C--O 1.245 0.817 0 CA-C-N 114.443 -1.253 . . . . 3.8100000000000001 111.643 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.633 0.254 . . . . 13.17 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -99.66 129.22 45.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 10.300000000000001 110.162 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.22 143.68 48.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 8.9100000000000001 110.594 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -80.69 65.62 5.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.315 0.579 . . . . 7.79 109.931 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.63 63.64 4.42 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.767 -0.651 . . . . 5.0199999999999996 112.641 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.93 -48.49 0.87 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.657 -0.577 . . . . 3.1600000000000001 111.657 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -121.62 143.23 49.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.197 -0.297 . . . . 1.51 110.197 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t -70.76 169.49 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.81999999999999995 109.92 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 0.47999999999999998 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.28000000000000003 111.644 174.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 0.53000000000000003 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.17 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 1.8999999999999999 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 0.41999999999999998 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 0.67000000000000004 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.0499999999999998 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.3799999999999999 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.3 81.62 7.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8 111.152 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.744 -0.662 . . . . 3.8100000000000001 109.468 177.205 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.111 0.481 . . . . 13.17 111.225 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -109.48 -20.9 12.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 10.300000000000001 109.755 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -78.65 130.15 35.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.689 . . . . 8.9100000000000001 110.044 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 t -72.84 117.58 14.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.063 0.459 . . . . 7.79 110.219 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 174.71 13.6 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.553 -0.748 . . . . 5.0199999999999996 111.585 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.36 92.93 0.45 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.571 -0.823 . . . . 3.1600000000000001 111.865 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.8 m -105.88 130.12 53.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.058 0.456 . . . . 1.51 110.643 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t -74.62 -178.99 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 110.452 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.28000000000000003 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 0.53000000000000003 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.1400000000000001 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 1.8999999999999999 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 0.41999999999999998 109.818 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 0.67000000000000004 113.384 173.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.0499999999999998 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.3799999999999999 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -103.57 -1.64 27.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8 110.263 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.072 -0.967 . . . . 3.8100000000000001 111.436 177.07 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.615 . . . . 13.17 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.67 -12.07 30.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.439 -0.346 . . . . 10.300000000000001 111.441 -170.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -91.6 81.8 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.949 0.404 . . . . 8.9100000000000001 110.204 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -81.55 -24.6 36.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.722 -0.672 . . . . 7.79 111.111 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.7 -175.59 28.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.661 -0.781 . . . . 5.0199999999999996 111.734 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 -67.23 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 3.1600000000000001 112.096 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 34.5 m -136.9 -115.8 0.17 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.602 -0.518 . . . . 1.51 109.602 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' H ' ' HB2' ' A' ' 11' ' ' TYR . 17.2 t -86.85 165.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 0.81999999999999995 108.878 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 0.47999999999999998 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.28000000000000003 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.681 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.53000000000000003 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.1400000000000001 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 1.8999999999999999 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 0.41999999999999998 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 0.67000000000000004 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.0499999999999998 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.3799999999999999 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p -88.57 78.7 7.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8 109.846 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.0 p90 . . . . . 0 C--O 1.242 0.684 0 CA-C-N 115.509 -0.769 . . . . 3.8100000000000001 110.617 -178.666 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.442 0.163 . . . . 13.17 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -99.78 -74.08 0.61 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.707 0.289 . . . . 10.300000000000001 111.647 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -91.32 23.43 3.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 8.9100000000000001 111.031 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m -84.5 104.36 14.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 7.79 110.972 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.96 -109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.628 -0.796 . . . . 5.0199999999999996 112.104 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.98 151.5 7.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.163 -0.541 . . . . 3.1600000000000001 112.352 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.5 m -140.98 146.36 37.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.784 0.326 . . . . 1.51 110.61 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t -73.85 168.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.768 -0.651 . . . . 0.81999999999999995 110.042 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.47999999999999998 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.28000000000000003 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 0.53000000000000003 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 1.8999999999999999 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 0.41999999999999998 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 0.67000000000000004 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.0499999999999998 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.3799999999999999 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -119.13 -18.65 8.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8 110.445 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 117.958 -1.02 . . . . 3.8100000000000001 110.801 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.823 0.344 . . . . 13.17 110.742 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.3 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.018 0.437 . . . . 10.300000000000001 110.386 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -81.65 -23.4 36.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.923 -0.58 . . . . 8.9100000000000001 111.214 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -82.95 7.35 15.75 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.315 0.487 . . . . 7.79 112.315 -173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.573 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -174.83 152.5 13.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.642 -1.266 . . . . 5.0199999999999996 112.934 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.15 37.64 1.31 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 109.882 -1.287 . . . . 3.1600000000000001 109.882 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.08 -157.69 0.58 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.586 -0.807 . . . . 1.51 109.591 -172.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t -62.25 160.55 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 0.81999999999999995 110.69 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 0.47999999999999998 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.28000000000000003 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.962 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 0.53000000000000003 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.1400000000000001 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.573 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 1.8999999999999999 111.044 -174.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 0.41999999999999998 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 0.67000000000000004 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.0499999999999998 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.3799999999999999 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p -86.79 91.18 8.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8 111.754 -174.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.7 p90 . . . . . 0 C--O 1.244 0.798 0 CA-C-N 115.43 -0.805 . . . . 3.8100000000000001 109.261 174.618 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.471 0.177 . . . . 13.17 110.8 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -79.19 -53.92 6.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 10.300000000000001 110.606 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -104.04 126.07 50.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.804 0.335 . . . . 8.9100000000000001 110.179 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -64.11 113.8 3.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 7.79 111.19 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -148.07 -178.85 23.57 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.908 -0.663 . . . . 5.0199999999999996 111.648 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.48 -34.38 5.62 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 3.1600000000000001 111.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 64.6 m -116.09 151.78 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.786 0.327 . . . . 1.51 110.744 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.6 t -82.49 172.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.81999999999999995 109.857 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.47999999999999998 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.28000000000000003 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 0.53000000000000003 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.1400000000000001 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 1.8999999999999999 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 0.41999999999999998 109.006 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 0.67000000000000004 113.289 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.0499999999999998 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.3799999999999999 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t -118.25 88.53 2.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8 109.089 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 p90 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.012 -0.994 . . . . 3.8100000000000001 110.936 -175.648 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.029 0.443 . . . . 13.17 110.432 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -95.58 83.85 3.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.469 -0.567 . . . . 10.300000000000001 109.469 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -124.02 136.62 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.099 -0.5 . . . . 8.9100000000000001 109.894 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 7' ' ' CYS . 8.8 m -74.09 -16.3 61.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.128 -0.487 . . . . 7.79 111.809 -175.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.2 -122.6 6.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.697 -0.763 . . . . 5.0199999999999996 113.125 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.98 -11.18 85.8 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.358 -0.449 . . . . 3.1600000000000001 112.921 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 13' ' ' ARG . 58.4 m -116.94 154.27 31.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.639 -0.504 . . . . 1.51 109.639 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' ALA . 5.9 t -78.39 169.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.083 -0.34 . . . . 0.81999999999999995 110.083 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.47999999999999998 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.28000000000000003 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 0.53000000000000003 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.1400000000000001 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 1.119 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 1.8999999999999999 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 0.41999999999999998 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 0.67000000000000004 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.0499999999999998 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 1.119 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.3799999999999999 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p -88.94 -31.59 18.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8 110.465 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.778 -1.105 . . . . 3.8100000000000001 110.103 -174.543 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.083 0.468 . . . . 13.17 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -83.55 104.58 13.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.317 0.579 . . . . 10.300000000000001 110.021 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -79.4 -1.07 35.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.484 -0.78 . . . . 8.9100000000000001 111.18 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -71.15 -30.38 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.089 -0.505 . . . . 7.79 110.019 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.93 126.88 1.29 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.091 -0.576 . . . . 5.0199999999999996 111.718 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.28 56.08 1.75 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 3.1600000000000001 112.486 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 15.8 m -139.58 159.34 42.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.897 0.379 . . . . 1.51 110.603 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' VAL . 3.3 t -65.45 163.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 110.569 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 111.906 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 0.53000000000000003 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.1400000000000001 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 0.41999999999999998 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 0.67000000000000004 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.0499999999999998 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.3799999999999999 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.659 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -107.12 -23.13 12.4 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8 109.503 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 56.2 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 114.936 -1.029 . . . . 3.8100000000000001 111.02 174.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.867 -0.049 . . . . 13.17 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.58 -59.86 0.21 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.218 0.451 . . . . 10.300000000000001 112.218 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -107.61 14.07 26.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.28 0.474 . . . . 8.9100000000000001 112.28 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 t -77.07 -22.97 52.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.61 0.243 . . . . 7.79 111.142 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.57 -140.99 3.25 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.771 -0.728 . . . . 5.0199999999999996 112.401 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.88 -35.03 1.96 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.842 -0.694 . . . . 3.1600000000000001 112.218 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 18.4 m -121.18 -160.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.428 . . . . 1.51 110.639 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.9 t -88.86 167.48 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.81999999999999995 109.764 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.28000000000000003 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 1.8999999999999999 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 0.41999999999999998 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 0.67000000000000004 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.0499999999999998 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.3799999999999999 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -98.93 94.08 6.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8 110.036 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.297 -0.858 . . . . 3.8100000000000001 110.703 -178.331 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.988 -0.375 . . . . 13.17 109.988 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -96.67 -60.77 1.53 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.681 -0.489 . . . . 10.300000000000001 109.681 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -97.88 115.05 27.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 8.9100000000000001 109.907 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 p -90.37 -67.22 0.86 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.211 0.529 . . . . 7.79 110.552 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.52 110.11 0.43 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.686 -0.688 . . . . 5.0199999999999996 111.928 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 -30.83 77.33 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.666 -0.778 . . . . 3.1600000000000001 112.325 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 10.1 m -142.52 162.05 36.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.659 0.266 . . . . 1.51 110.542 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 9' ' ' ALA . 2.8 t -71.63 168.55 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.755 -0.657 . . . . 0.81999999999999995 111.152 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 0.47999999999999998 110.779 174.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.28000000000000003 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 0.53000000000000003 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.1400000000000001 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 0.41999999999999998 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 0.67000000000000004 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.0499999999999998 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.3799999999999999 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -110.21 -7.79 14.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8 110.148 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.372 -0.831 . . . . 3.8100000000000001 111.444 177.708 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.032 0.444 . . . . 13.17 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -101.15 103.98 15.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.431 . . . . 10.300000000000001 110.093 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -97.23 -25.44 15.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.063 0.458 . . . . 8.9100000000000001 110.776 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 t -81.56 13.4 3.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 7.79 111.53 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.1 -24.94 65.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.719 -0.753 . . . . 5.0199999999999996 112.452 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.31 -174.68 46.53 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.159 -0.776 . . . . 3.1600000000000001 111.159 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 165.87 25.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.696 0.284 . . . . 1.51 110.625 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.723 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t -73.72 165.51 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.27 -0.423 . . . . 0.81999999999999995 110.216 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 0.47999999999999998 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.28000000000000003 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.723 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 0.53000000000000003 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.1400000000000001 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 1.8999999999999999 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 0.41999999999999998 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 0.67000000000000004 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.0499999999999998 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.632 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.3799999999999999 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t -97.11 97.94 9.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8 111.172 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.686 -1.143 . . . . 3.8100000000000001 108.857 173.174 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 111.866 0.321 . . . . 13.17 111.866 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.94 152.97 23.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.797 -0.445 . . . . 10.300000000000001 109.797 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -125.7 -40.91 2.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.824 0.345 . . . . 8.9100000000000001 111.341 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 t -71.47 121.18 18.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.833 -0.347 . . . . 7.79 110.811 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.31 85.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.027 -0.606 . . . . 5.0199999999999996 112.578 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.77 146.47 4.7 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.578 -0.82 . . . . 3.1600000000000001 112.446 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.24 -175.53 5.02 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.028 -0.36 . . . . 1.51 110.028 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t -59.62 154.39 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.509 0.323 . . . . 0.81999999999999995 111.214 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 0.47999999999999998 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.28000000000000003 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 0.53000000000000003 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.1400000000000001 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 1.8999999999999999 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 0.41999999999999998 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 0.67000000000000004 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.0499999999999998 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.3799999999999999 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.625 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -125.21 21.51 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8 110.27 -174.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 3.8100000000000001 110.879 178.331 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 0.81999999999999995 110.252 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 0.47999999999999998 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.28000000000000003 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.53000000000000003 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.1400000000000001 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 1.8999999999999999 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 0.41999999999999998 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.0499999999999998 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.3799999999999999 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8 110.999 -176.889 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 9' ' ' ALA . 13.0 t . . . . . 0 CA--C 1.541 0.596 0 CA-C-O 120.485 0.183 . . . . 0.81999999999999995 111.022 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.468 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 0.47999999999999998 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.28000000000000003 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.655 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 0.53000000000000003 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.1400000000000001 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 1.8999999999999999 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 0.41999999999999998 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 0.67000000000000004 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.0499999999999998 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.711 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.3799999999999999 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8 109.872 177.849 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.8 t . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.522 -0.548 . . . . 0.81999999999999995 109.522 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 0.47999999999999998 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.28000000000000003 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 0.53000000000000003 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.1400000000000001 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 1.8999999999999999 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 0.41999999999999998 109.516 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 113.716 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.0499999999999998 108.361 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.3799999999999999 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p . . . . . 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8 111.112 -176.882 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.0 t . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 0.81999999999999995 109.435 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 0.47999999999999998 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.28000000000000003 112.397 178.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.931 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 0.53000000000000003 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.1400000000000001 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 1.8999999999999999 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 0.67000000000000004 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.0499999999999998 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.3799999999999999 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8 109.655 178.158 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 9' ' ' ALA . 4.9 t . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 110.318 -0.253 . . . . 0.81999999999999995 110.318 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 0.47999999999999998 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.28000000000000003 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 0.53000000000000003 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.1400000000000001 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.782 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 1.8999999999999999 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 0.41999999999999998 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 0.67000000000000004 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.0499999999999998 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.839 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.3799999999999999 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.839 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8 110.025 174.047 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t . . . . . 0 CA--C 1.532 0.275 0 N-CA-C 110.381 -0.229 . . . . 0.81999999999999995 110.381 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 0.47999999999999998 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.28000000000000003 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 0.53000000000000003 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.1400000000000001 110.093 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 1.8999999999999999 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 0.41999999999999998 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 0.67000000000000004 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.0499999999999998 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.836 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.3799999999999999 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8 110.349 176.482 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.4 t . . . . . 0 CA--C 1.533 0.291 0 N-CA-C 109.785 -0.45 . . . . 0.81999999999999995 109.785 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.47999999999999998 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.28000000000000003 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 0.53000000000000003 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.1400000000000001 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 1.8999999999999999 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 16' ' ' ASP . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 0.41999999999999998 110.496 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 0.67000000000000004 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.0499999999999998 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8 110.847 -174.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.1 t . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 109.368 -0.604 . . . . 0.81999999999999995 109.368 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.691 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 0.47999999999999998 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.28000000000000003 111.971 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 0.53000000000000003 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.807 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 1.8999999999999999 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 0.41999999999999998 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 0.67000000000000004 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.0499999999999998 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.807 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.3799999999999999 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t . . . . . 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8 108.909 171.678 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.92 -0.4 . . . . 0.81999999999999995 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.462 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 0.47999999999999998 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.28000000000000003 111.644 174.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 0.53000000000000003 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.17 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 1.8999999999999999 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 0.41999999999999998 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 0.67000000000000004 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.0499999999999998 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.3799999999999999 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8 111.152 -175.413 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t . . . . . 0 C--O 1.234 0.24 0 CA-C-O 120.729 0.3 . . . . 0.81999999999999995 110.452 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.28000000000000003 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 0.53000000000000003 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.1400000000000001 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 1.8999999999999999 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 0.41999999999999998 109.818 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 0.67000000000000004 113.384 173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.0499999999999998 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.3799999999999999 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8 110.263 -178.914 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 11' ' ' TYR . 17.2 t . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 108.878 -0.786 . . . . 0.81999999999999995 108.878 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 0.47999999999999998 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.28000000000000003 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.681 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.53000000000000003 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.1400000000000001 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 1.8999999999999999 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 0.41999999999999998 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 0.67000000000000004 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.0499999999999998 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.3799999999999999 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8 109.846 176.24 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t . . . . . 0 C--O 1.234 0.247 0 N-CA-C 110.042 -0.355 . . . . 0.81999999999999995 110.042 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.426 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.47999999999999998 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.28000000000000003 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 0.53000000000000003 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 1.8999999999999999 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 0.41999999999999998 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 0.67000000000000004 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.0499999999999998 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.3799999999999999 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8 110.445 176.669 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t . . . . . 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 0.81999999999999995 110.69 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 0.47999999999999998 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.28000000000000003 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.962 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 0.53000000000000003 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.1400000000000001 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 1.8999999999999999 111.044 -174.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 0.41999999999999998 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 0.67000000000000004 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.0499999999999998 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.3799999999999999 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p . . . . . 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8 111.754 -174.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.6 t . . . . . 0 C--O 1.234 0.28 0 N-CA-C 109.857 -0.423 . . . . 0.81999999999999995 109.857 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.47999999999999998 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.28000000000000003 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 0.53000000000000003 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.1400000000000001 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 1.8999999999999999 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 0.41999999999999998 109.006 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 0.67000000000000004 113.289 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.0499999999999998 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.3799999999999999 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8 109.089 173.181 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' ALA . 5.9 t . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 110.083 -0.34 . . . . 0.81999999999999995 110.083 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.47999999999999998 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.28000000000000003 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 0.53000000000000003 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.1400000000000001 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 1.119 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 1.8999999999999999 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 0.41999999999999998 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 0.67000000000000004 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.0499999999999998 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 1.119 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.3799999999999999 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8 110.465 -176.224 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 120.458 0.171 . . . . 0.81999999999999995 110.569 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 111.906 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 0.53000000000000003 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.1400000000000001 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 0.41999999999999998 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 0.67000000000000004 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.0499999999999998 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.3799999999999999 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.659 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8 109.503 -176.92 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.9 t . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 109.764 -0.458 . . . . 0.81999999999999995 109.764 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.28000000000000003 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 1.8999999999999999 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 0.41999999999999998 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 0.67000000000000004 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.0499999999999998 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.3799999999999999 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t . . . . . 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8 110.036 177.992 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 9' ' ' ALA . 2.8 t . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.399 0.143 . . . . 0.81999999999999995 111.152 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.402 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 0.47999999999999998 110.779 174.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.28000000000000003 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 0.53000000000000003 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.1400000000000001 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 0.41999999999999998 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 0.67000000000000004 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.0499999999999998 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.3799999999999999 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t . . . . . 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8 110.148 178.6 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.723 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 110.216 -0.29 . . . . 0.81999999999999995 110.216 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 0.47999999999999998 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.28000000000000003 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.723 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 0.53000000000000003 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.1400000000000001 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 1.8999999999999999 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 0.41999999999999998 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 0.67000000000000004 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.0499999999999998 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.632 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.3799999999999999 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8 111.172 -176.6 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t . . . . . 0 N--CA 1.466 0.343 0 CA-C-O 120.619 0.247 . . . . 0.81999999999999995 111.214 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 0.47999999999999998 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.28000000000000003 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 0.53000000000000003 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.1400000000000001 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 1.8999999999999999 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 0.41999999999999998 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 0.67000000000000004 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.0499999999999998 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.3799999999999999 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.625 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8 110.27 -174.281 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.88 -0.415 . . . . 13.17 109.88 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -79.63 111.64 16.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.991 0.424 . . . . 10.300000000000001 110.88 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -109.89 -0.07 18.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.385 0.612 . . . . 8.9100000000000001 109.82 174.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 16.2 m -91.37 25.21 2.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.614 -0.721 . . . . 7.79 110.794 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -167.37 -82.66 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.683 -0.77 . . . . 5.0199999999999996 112.505 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 154.09 -45.86 0.56 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.932 -0.651 . . . . 3.1600000000000001 111.808 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 11' ' ' TYR . 11.8 m -118.1 -159.84 0.76 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.548 -0.538 . . . . 1.51 109.548 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.675 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 18.0 t -62.04 162.71 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 N-CA-C 110.252 -0.277 . . . . 0.81999999999999995 110.252 176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -52.98 -40.52 63.83 Favored 'General case' 0 N--CA 1.468 0.467 0 O-C-N 122.267 -0.27 . . . . 0.47999999999999998 111.725 178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.41 19.61 38.97 Favored Glycine 0 C--O 1.237 0.296 0 C-N-CA 121.285 -0.483 . . . . 0.28000000000000003 112.304 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.821 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 67.5 m-85 -136.73 95.85 3.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.016 0.436 . . . . 0.53000000000000003 110.425 178.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.418 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 54.9 mtt -84.05 115.58 22.43 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.254 -0.647 . . . . 2.1400000000000001 109.254 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -68.15 149.02 50.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.71 0.767 . . . . 1.8999999999999999 110.753 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.0 p -118.72 157.46 49.93 Favored Pre-proline 0 C--N 1.313 -0.987 0 CA-C-N 114.826 -1.079 . . . . 0.41999999999999998 110.105 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -67.73 -0.93 5.91 Favored 'Trans proline' 0 CA--C 1.528 0.217 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 111.742 173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -79.97 -10.05 59.74 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 122.158 0.98 . . . . 1.95 108.508 171.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 77.58 20.72 73.78 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.02 -1.446 . . . . 0.51000000000000001 110.963 -177.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.2 ttm180 -111.91 162.94 14.77 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.615 -0.883 . . . . 3.0499999999999998 108.615 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 59.6 m -106.22 132.89 51.74 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.191 -0.67 . . . . 0.59999999999999998 109.191 175.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.8 tptt -77.64 109.12 8.66 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 109.395 -0.594 . . . . 1.3799999999999999 109.395 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -84.41 96.12 0.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.766 2.311 . . . . 0.58999999999999997 111.858 -175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.0 t -103.31 -14.86 16.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.075 -0.511 . . . . 1.8 110.999 -176.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.2 m-85 . . . . . 0 C--O 1.245 0.848 0 CA-C-O 118.607 -0.711 . . . . 3.8100000000000001 110.702 -177.198 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.91 0.386 . . . . 13.17 110.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 26.9 p-10 -94.81 170.47 9.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.127 -0.488 . . . . 10.300000000000001 109.791 176.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -98.29 129.57 44.99 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.194 -0.669 . . . . 8.9100000000000001 109.194 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.41 ' OG ' ' HB2' ' A' ' 7' ' ' CYS . 6.7 t -67.91 -28.01 67.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.118 0.485 . . . . 7.79 111.48 -176.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.5 -104.24 3.09 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.749 -0.739 . . . . 5.0199999999999996 112.595 177.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.75 12.08 66.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.013 -0.613 . . . . 3.1600000000000001 112.41 -177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.551 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 21.6 m -108.11 151.35 26.0 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.966 -0.383 . . . . 1.51 109.966 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 9' ' ' ALA . 13.0 t -63.27 167.74 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-N 116.359 -0.382 . . . . 0.81999999999999995 111.022 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.6 -38.18 80.55 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.707 0.289 . . . . 0.47999999999999998 111.471 178.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.15 18.71 30.6 Favored Glycine 0 C--N 1.332 0.353 0 N-CA-C 111.548 -0.621 . . . . 0.28000000000000003 111.548 175.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.655 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 21.2 m-85 -132.52 82.39 2.01 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 109.428 -0.582 . . . . 0.53000000000000003 109.428 176.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 75.5 mtm -89.29 113.34 24.59 Favored 'General case' 0 C--N 1.318 -0.79 0 C-N-CA 120.455 -0.498 . . . . 2.1400000000000001 109.926 -177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.74 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 17.5 ptt180 -57.13 143.45 38.73 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.605 0.716 . . . . 1.8999999999999999 112.001 -173.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 73.7 p -105.93 163.26 17.42 Favored Pre-proline 0 C--N 1.315 -0.915 0 CA-C-N 115.158 -0.928 . . . . 0.41999999999999998 109.657 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -58.0 -6.69 2.87 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 123.299 2.666 . . . . 0.67000000000000004 113.154 170.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -79.37 -18.69 51.86 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.654 0.74 . . . . 1.95 109.535 174.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 89.92 4.61 72.01 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.205 -0.907 . . . . 0.51000000000000001 111.058 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -103.09 140.8 36.85 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.772 -0.825 . . . . 3.0499999999999998 108.772 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.74 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 3.3 m -80.63 133.04 35.68 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.173 -1.047 . . . . 0.59999999999999998 108.173 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.711 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 21.8 tptm -77.12 109.76 10.11 Favored Pre-proline 0 CA--C 1.514 -0.441 0 N-CA-C 109.229 -0.656 . . . . 1.3799999999999999 109.229 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.711 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 63.1 Cg_endo -85.86 94.77 0.59 Allowed 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.25 2.634 . . . . 0.58999999999999997 112.546 -172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 15.3 t -107.07 -9.55 16.16 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.919 -0.582 . . . . 1.8 109.872 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 C--O 1.252 1.207 0 CA-C-N 115.397 -0.82 . . . . 3.8100000000000001 111.134 176.444 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.715 -0.476 . . . . 13.17 109.715 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -161.37 -36.67 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 121.119 0.485 . . . . 10.300000000000001 111.555 -174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -84.42 6.57 22.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 8.9100000000000001 111.558 -175.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.27 55.87 1.96 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.144 0.497 . . . . 7.79 111.388 -176.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -87.44 55.99 4.49 Favored Glycine 0 N--CA 1.451 -0.352 0 CA-C-N 115.996 -0.547 . . . . 5.0199999999999996 112.589 -178.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.57 -48.9 0.95 Allowed Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.983 -0.627 . . . . 3.1600000000000001 112.09 176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.3 m -84.77 130.21 34.71 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 120.764 0.316 . . . . 1.51 110.685 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.709 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.8 t -90.76 -172.53 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 N-CA-C 109.522 -0.548 . . . . 0.81999999999999995 109.522 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.709 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.43 -18.96 65.21 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.022 0.439 . . . . 0.47999999999999998 111.469 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -93.31 19.23 53.72 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.157 -0.544 . . . . 0.28000000000000003 111.84 174.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.546 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 21.0 m-85 -136.66 91.26 2.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.114 0.483 . . . . 0.53000000000000003 110.479 177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.511 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 86.7 mmm -83.43 96.59 8.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.001 -0.545 . . . . 2.1400000000000001 110.284 -178.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.641 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 23.2 ttt180 -58.34 134.95 57.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.291 0.567 . . . . 1.8999999999999999 111.758 -179.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.413 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 71.0 p -102.53 167.86 9.75 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.501 -0.772 . . . . 0.41999999999999998 109.516 174.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 74.7 Cg_exo -53.62 -10.08 1.4 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 123.278 2.652 . . . . 0.67000000000000004 113.716 171.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -79.58 -24.2 42.23 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.417 0.627 . . . . 1.95 109.922 176.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 96.01 -15.47 62.94 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 110.838 -0.905 . . . . 0.51000000000000001 110.838 -174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -79.05 137.03 37.36 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.361 -0.977 . . . . 3.0499999999999998 108.361 173.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 88.7 m -99.57 139.22 35.55 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 120.476 -0.49 . . . . 0.59999999999999998 109.736 -177.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 46.9 tptt -78.0 110.44 13.29 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 109.054 -0.721 . . . . 1.3799999999999999 109.054 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.601 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 65.9 Cg_endo -81.61 143.68 13.63 Favored 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.575 2.183 . . . . 0.58999999999999997 111.29 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 37.1 p -88.04 47.19 1.47 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.269 0.557 . . . . 1.8 111.112 -176.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-N 115.219 -0.901 . . . . 3.8100000000000001 109.432 179.044 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 109.897 -0.409 . . . . 13.17 109.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -114.39 99.26 7.45 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.003 -0.369 . . . . 10.300000000000001 110.003 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -95.38 -21.37 18.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.647 0.737 . . . . 8.9100000000000001 110.015 176.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 22.1 p -67.58 123.45 20.49 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.627 -0.715 . . . . 7.79 110.664 176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.61 83.63 0.37 Allowed Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.118 -0.563 . . . . 5.0199999999999996 112.107 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -139.93 88.05 0.2 Allowed Glycine 0 CA--C 1.501 -0.831 0 N-CA-C 110.225 -1.15 . . . . 3.1600000000000001 110.225 -178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.466 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 70.2 m -102.3 147.48 26.63 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.485 -0.358 . . . . 1.51 111.227 -170.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.0 t -81.29 175.2 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 N-CA-C 109.435 -0.58 . . . . 0.81999999999999995 109.435 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.578 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -52.53 -37.46 57.68 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 120.841 0.353 . . . . 0.47999999999999998 111.761 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.7 29.14 7.59 Favored Glycine 0 CA--C 1.508 -0.364 0 C-N-CA 121.108 -0.568 . . . . 0.28000000000000003 112.397 178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.931 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 86.4 m-85 -141.98 115.9 9.28 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.881 0.372 . . . . 0.53000000000000003 110.326 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 93.0 mtp -101.56 122.42 43.81 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.409 -0.36 . . . . 2.1400000000000001 110.297 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.0 ttp180 -65.68 124.99 23.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.491 -0.322 . . . . 1.8999999999999999 110.587 -177.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.496 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 42.2 p -84.03 163.05 50.05 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.382 -0.599 . . . . 0.41999999999999998 109.382 175.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.496 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 6.9 Cg_endo -53.2 -14.75 4.43 Favored 'Trans proline' 0 CA--C 1.535 0.562 0 C-N-CA 123.192 2.594 . . . . 0.67000000000000004 113.054 174.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -80.31 -40.97 25.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.309 0.576 . . . . 1.95 109.97 176.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -6.66 10.62 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.263 -0.88 . . . . 0.51000000000000001 111.204 -172.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -79.52 154.56 28.74 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.802 -0.444 . . . . 3.0499999999999998 109.802 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 74.8 m -97.36 130.75 44.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 110.319 -0.252 . . . . 0.59999999999999998 110.319 -179.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 48.2 tptt -77.04 109.6 9.53 Favored Pre-proline 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 1.3799999999999999 108.997 176.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.595 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 55.2 Cg_endo -83.9 84.53 1.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.084 0 C-N-CA 122.578 2.185 . . . . 0.58999999999999997 112.856 -171.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.8 t -93.72 -18.01 22.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.707 -0.679 . . . . 1.8 109.655 178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.445 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 72.0 m-85 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.266 -0.873 . . . . 3.8100000000000001 110.738 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 . . . . . 0 N--CA 1.48 1.039 0 CA-C-O 120.677 0.275 . . . . 13.17 110.969 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -81.36 27.28 0.43 Allowed 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.197 -0.456 . . . . 10.300000000000001 111.608 -171.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -160.22 -18.92 0.06 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.196 0.522 . . . . 8.9100000000000001 110.618 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.4 p -88.76 96.06 10.52 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.919 -0.582 . . . . 7.79 111.281 -176.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.93 112.61 0.32 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.825 -0.703 . . . . 5.0199999999999996 112.296 178.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.76 23.34 6.67 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.808 -0.711 . . . . 3.1600000000000001 112.214 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.434 ' HB3' ' CB ' ' A' ' 11' ' ' TYR . 97.4 m -93.31 177.15 6.13 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.682 0.277 . . . . 1.51 110.896 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.422 HG12 ' N ' ' A' ' 9' ' ' ALA . 4.9 t -71.11 166.41 2.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 116.165 -0.471 . . . . 0.81999999999999995 110.318 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.422 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.06 -32.18 69.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.735 0.302 . . . . 0.47999999999999998 110.74 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.55 24.43 20.13 Favored Glycine 0 C--N 1.333 0.391 0 CA-C-N 116.016 -0.538 . . . . 0.28000000000000003 111.815 177.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 19.7 m-85 -137.91 83.36 1.97 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.42 0.628 . . . . 0.53000000000000003 109.642 175.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 41.9 mtt -86.71 114.45 23.41 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.374 -0.83 . . . . 2.1400000000000001 108.945 -177.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.782 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.7 ptt180 -60.63 148.83 37.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 CA-C-O 121.495 0.664 . . . . 1.8999999999999999 111.783 -168.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.0 p -108.77 157.25 37.27 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-N 115.011 -0.995 . . . . 0.41999999999999998 110.31 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.48 -1.76 4.29 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.102 2.535 . . . . 0.67000000000000004 111.743 171.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -79.04 -39.34 34.19 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.166 -0.679 . . . . 1.95 109.166 171.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.73 -29.65 4.16 Favored Glycine 0 N--CA 1.444 -0.815 0 CA-C-N 115.179 -0.918 . . . . 0.51000000000000001 111.885 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.0 ptp180 -80.4 175.92 10.23 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.246 -0.65 . . . . 3.0499999999999998 109.246 175.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.782 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.0 m -107.45 142.91 36.56 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.535 -0.543 . . . . 0.59999999999999998 109.535 177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.839 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 27.5 tptp -77.79 113.15 29.91 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-O 121.007 0.432 . . . . 1.3799999999999999 109.857 -175.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.839 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 93.0 Cg_endo -79.51 136.88 12.68 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.068 2.512 . . . . 0.58999999999999997 112.496 -175.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.2 p -95.81 15.0 21.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.438 0.637 . . . . 1.8 110.025 174.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 C--O 1.245 0.865 0 CA-C-N 115.326 -0.852 . . . . 3.8100000000000001 109.648 -179.499 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.137 0 CA-C-O 120.716 0.293 . . . . 13.17 110.465 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -79.92 -41.47 26.01 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.8 -0.636 . . . . 10.300000000000001 111.067 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -87.37 146.05 26.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.89 0.376 . . . . 8.9100000000000001 110.483 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.4 m -90.5 162.43 15.05 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.901 -0.59 . . . . 7.79 110.3 177.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -97.34 -172.33 33.74 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.758 -0.734 . . . . 5.0199999999999996 112.124 179.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.04 73.25 0.46 Allowed Glycine 0 N--CA 1.449 -0.437 0 N-CA-C 111.63 -0.588 . . . . 3.1600000000000001 111.63 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.1 m -88.6 126.2 35.17 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.823 0.344 . . . . 1.51 110.724 -177.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.5 t -85.32 -171.4 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.689 -0.687 . . . . 0.81999999999999995 110.381 -176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.704 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -64.18 -30.27 71.34 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.637 0.256 . . . . 0.47999999999999998 111.022 179.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.3 21.3 32.44 Favored Glycine 0 CA--C 1.511 -0.182 0 C-N-CA 121.077 -0.582 . . . . 0.28000000000000003 111.703 176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.549 ' CE1' ' HB3' ' A' ' 21' ' ' PRO . 15.5 m-85 -126.15 84.55 2.28 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.653 -0.499 . . . . 0.53000000000000003 109.653 174.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.421 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 71.8 mtm -81.47 97.29 7.71 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.861 -0.609 . . . . 2.1400000000000001 110.093 -177.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.836 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 9.8 ttp180 -61.37 130.37 45.75 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.963 -0.562 . . . . 1.8999999999999999 111.031 -178.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.45 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 34.5 p -85.72 158.2 56.97 Favored Pre-proline 0 C--N 1.317 -0.805 0 N-CA-C 108.924 -0.769 . . . . 0.41999999999999998 108.924 173.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -54.89 -7.91 1.15 Allowed 'Trans proline' 0 CA--C 1.533 0.458 0 C-N-CA 123.18 2.587 . . . . 0.67000000000000004 113.362 176.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -78.89 -34.59 44.68 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.469 -0.567 . . . . 1.95 109.469 175.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 118.63 -8.13 13.37 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.569 -0.742 . . . . 0.51000000000000001 112.338 -178.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.0 tpp180 -90.4 135.43 33.69 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.122 -0.695 . . . . 3.0499999999999998 109.122 176.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.836 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 73.7 m -92.66 138.67 31.3 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 120.592 -0.443 . . . . 0.59999999999999998 109.985 -177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 24.2 tptm -79.06 107.88 7.1 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.996 -0.547 . . . . 1.3799999999999999 109.697 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -86.39 106.5 0.78 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 122.873 2.382 . . . . 0.58999999999999997 112.888 -174.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.2 t -116.26 100.32 7.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.648 0.737 . . . . 1.8 110.349 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 C--O 1.242 0.686 0 CA-C-N 115.5 -0.773 . . . . 3.8100000000000001 110.062 177.238 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 110.099 -0.334 . . . . 13.17 110.099 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -105.89 130.98 53.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.828 -0.434 . . . . 10.300000000000001 109.828 176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -121.64 169.36 10.78 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.354 -0.385 . . . . 8.9100000000000001 111.006 -176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 17.1 m -63.71 110.54 2.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.674 -0.694 . . . . 7.79 111.723 -176.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -147.98 28.67 1.41 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.679 -0.691 . . . . 5.0199999999999996 111.706 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.99 32.93 7.03 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.179 -0.534 . . . . 3.1600000000000001 111.96 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 70.8 m -85.05 108.09 17.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.154 0.502 . . . . 1.51 110.821 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.683 HG12 ' H ' ' A' ' 9' ' ' ALA . 1.4 t -85.3 -166.13 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.338 -0.846 . . . . 0.81999999999999995 109.785 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.683 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -62.95 -22.64 66.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.096 0.474 . . . . 0.47999999999999998 110.982 178.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.17 13.55 59.51 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.965 -0.636 . . . . 0.28000000000000003 111.89 176.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 31.8 m-85 -139.57 94.56 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 122.523 0.329 . . . . 0.53000000000000003 110.663 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 61.6 mtm -90.95 107.38 19.16 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.162 -0.681 . . . . 2.1400000000000001 109.162 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.805 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.1 ptt180 -62.73 150.85 40.14 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.406 0.622 . . . . 1.8999999999999999 111.395 -174.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.41 ' OG1' ' HB3' ' A' ' 16' ' ' ASP . 70.6 p -111.69 162.55 20.61 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.326 -0.852 . . . . 0.41999999999999998 110.496 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.95 -7.08 7.08 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.261 2.641 . . . . 0.67000000000000004 112.265 171.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.41 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 3.3 t70 -78.66 -32.12 47.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.608 -0.723 . . . . 1.95 109.656 173.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 115.99 -28.54 7.61 Favored Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.455 -0.793 . . . . 0.51000000000000001 111.776 -179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -79.44 159.46 27.01 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.599 -0.519 . . . . 3.0499999999999998 109.599 176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.805 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 98.6 m -103.59 143.47 32.7 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 0.59999999999999998 109.777 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.647 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 52.4 tptt -78.24 112.44 25.85 Favored Pre-proline 0 N--CA 1.448 -0.547 0 CA-C-N 115.963 -0.562 . . . . 1.3799999999999999 109.613 178.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.647 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 74.3 Cg_endo -81.41 102.52 1.32 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.66 2.24 . . . . 0.58999999999999997 111.59 -178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 t -115.58 13.69 16.39 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.358 -0.837 . . . . 1.8 110.847 -174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 14.0 p90 . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.521 -0.752 . . . . 3.8100000000000001 110.222 -179.025 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.151 -0.315 . . . . 13.17 110.151 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -103.22 155.3 18.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.986 0.422 . . . . 10.300000000000001 111.299 -178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -106.46 109.35 21.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.952 -0.567 . . . . 8.9100000000000001 110.193 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.7 t -90.55 115.6 27.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.021 -0.536 . . . . 7.79 110.296 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.02 153.67 6.51 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 119.921 -1.133 . . . . 5.0199999999999996 113.474 177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 104.05 -34.53 5.71 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.279 -0.486 . . . . 3.1600000000000001 112.654 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.2 m -107.11 123.91 48.91 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.891 0.377 . . . . 1.51 111.043 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.691 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.1 t -82.19 -179.58 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-N 115.863 -0.608 . . . . 0.81999999999999995 109.368 178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.691 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -60.76 -28.51 68.77 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.843 0.354 . . . . 0.47999999999999998 110.84 178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -86.03 17.66 35.82 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 116.037 -0.529 . . . . 0.28000000000000003 111.971 176.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.641 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 31.2 m-85 -116.92 95.02 4.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.098 0.475 . . . . 0.53000000000000003 109.857 172.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.807 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 77.6 mtp -79.26 90.37 4.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.542 -0.754 . . . . 2.1400000000000001 109.271 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.778 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 25.4 ptt180 -64.13 144.54 57.03 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.172 0.51 . . . . 1.8999999999999999 110.965 -176.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 69.5 p -102.86 159.16 30.14 Favored Pre-proline 0 C--N 1.316 -0.888 0 N-CA-C 108.993 -0.743 . . . . 0.41999999999999998 108.993 174.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -59.65 -9.02 8.29 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 123.094 2.53 . . . . 0.67000000000000004 112.725 175.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -79.27 -28.03 42.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.407 0.622 . . . . 1.95 110.265 174.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 108.79 -7.0 33.34 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.679 -0.691 . . . . 0.51000000000000001 111.677 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -81.77 128.08 33.62 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.424 -0.584 . . . . 3.0499999999999998 109.424 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.8 m -95.66 134.27 38.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.814 0.34 . . . . 0.59999999999999998 110.169 179.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.807 ' HB3' ' HB2' ' A' ' 12' ' ' MET . 55.4 tptt -78.75 108.05 7.24 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.777 -0.647 . . . . 1.3799999999999999 109.305 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 98.0 Cg_endo -86.73 96.82 0.5 Allowed 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.684 2.256 . . . . 0.58999999999999997 113.708 -171.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.5 t -106.05 -7.17 18.18 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.909 -0.775 . . . . 1.8 108.909 171.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.538 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 81.2 m-85 . . . . . 0 C--O 1.245 0.817 0 CA-C-N 114.443 -1.253 . . . . 3.8100000000000001 111.643 174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.633 0.254 . . . . 13.17 110.868 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 41.1 t-20 -99.66 129.22 45.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.87 0.367 . . . . 10.300000000000001 110.162 -175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -120.22 143.68 48.14 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.06 -0.518 . . . . 8.9100000000000001 110.594 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 19.2 m -80.69 65.62 5.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.315 0.579 . . . . 7.79 109.931 177.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -83.63 63.64 4.42 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.767 -0.651 . . . . 5.0199999999999996 112.641 -176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.93 -48.49 0.87 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.657 -0.577 . . . . 3.1600000000000001 111.657 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.2 m -121.62 143.23 49.44 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 110.197 -0.297 . . . . 1.51 110.197 179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.462 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.0 t -70.76 169.49 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.961 -0.563 . . . . 0.81999999999999995 109.92 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.462 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.71 -28.87 66.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.073 0.464 . . . . 0.47999999999999998 110.676 175.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 21' ' ' PRO . . . -90.18 32.6 4.85 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.771 -0.65 . . . . 0.28000000000000003 111.644 174.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.778 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 21.0 m-85 -139.75 82.15 1.86 Allowed 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 123.112 0.565 . . . . 0.53000000000000003 109.634 175.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.41 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 26.3 mmt -80.21 104.22 10.62 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.17 -178.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.547 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 14.0 ptt180 -58.51 135.76 57.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.928 0.394 . . . . 1.8999999999999999 110.454 -179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 64.8 p -105.17 167.27 10.04 Favored Pre-proline 0 C--N 1.319 -0.733 0 N-CA-C 109.875 -0.417 . . . . 0.41999999999999998 109.875 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 73.7 Cg_exo -52.02 -12.64 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.326 2.684 . . . . 0.67000000000000004 113.545 173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.85 -27.08 44.12 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.316 0.579 . . . . 1.95 109.924 177.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 99.22 -5.61 59.21 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.441 -0.8 . . . . 0.51000000000000001 111.487 -174.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 35.0 ttm180 -81.09 150.71 28.66 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.865 -0.791 . . . . 3.0499999999999998 108.865 172.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.778 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.1 m -103.92 129.52 51.45 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.388 -0.597 . . . . 0.59999999999999998 109.388 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.2 tptm -77.01 109.76 9.97 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.985 -0.552 . . . . 1.3799999999999999 109.85 -175.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 61.0 Cg_endo -83.98 124.53 3.42 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 122.655 2.237 . . . . 0.58999999999999997 111.849 -174.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.6 p -88.3 81.62 7.24 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.503 0.668 . . . . 1.8 111.152 -175.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-N 115.744 -0.662 . . . . 3.8100000000000001 109.468 177.205 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.481 1.093 0 CA-C-O 121.111 0.481 . . . . 13.17 111.225 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -109.48 -20.9 12.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.738 -0.664 . . . . 10.300000000000001 109.755 176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -78.65 130.15 35.54 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.683 -0.689 . . . . 8.9100000000000001 110.044 -177.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.3 t -72.84 117.58 14.72 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.063 0.459 . . . . 7.79 110.219 -177.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 134.16 174.71 13.6 Favored Glycine 0 N--CA 1.443 -0.869 0 CA-C-N 115.553 -0.748 . . . . 5.0199999999999996 111.585 -178.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 134.36 92.93 0.45 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.571 -0.823 . . . . 3.1600000000000001 111.865 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.524 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 95.8 m -105.88 130.12 53.91 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.058 0.456 . . . . 1.51 110.643 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' H ' ' A' ' 9' ' ' ALA . 2.2 t -74.62 -178.99 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.564 -0.744 . . . . 0.81999999999999995 110.452 -176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.717 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -55.86 -33.66 64.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.47999999999999998 111.469 177.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -89.8 22.6 24.21 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.081 -0.581 . . . . 0.28000000000000003 112.177 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.524 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 35.6 m-85 -133.75 96.9 3.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.849 0.357 . . . . 0.53000000000000003 110.405 176.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -93.43 106.83 18.76 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.272 -0.422 . . . . 2.1400000000000001 110.27 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 24.5 ttp180 -61.34 128.47 36.52 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.999 -0.28 . . . . 1.8999999999999999 111.077 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.42 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 50.4 p -92.91 168.1 13.02 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 116.172 -0.467 . . . . 0.41999999999999998 109.818 176.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 60.0 Cg_exo -55.49 -8.35 1.82 Allowed 'Trans proline' 0 CA--C 1.534 0.514 0 C-N-CA 123.267 2.645 . . . . 0.67000000000000004 113.384 173.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.58 -31.12 47.12 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.358 -0.608 . . . . 1.95 109.358 175.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.77 -16.93 43.05 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.27 -0.877 . . . . 0.51000000000000001 110.994 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -80.24 147.69 31.12 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 108.797 -0.816 . . . . 3.0499999999999998 108.797 173.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.636 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 95.7 m -97.65 142.26 29.67 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 120.35 -0.54 . . . . 0.59999999999999998 110.042 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 23.6 tptm -77.83 109.83 11.1 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.581 -0.736 . . . . 1.3799999999999999 109.08 179.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 92.0 Cg_endo -85.06 91.85 0.72 Allowed 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.752 2.301 . . . . 0.58999999999999997 111.888 -175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.5 t -103.57 -1.64 27.95 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.539 -0.755 . . . . 1.8 110.263 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 . . . . . 0 C--O 1.247 0.932 0 CA-C-N 115.072 -0.967 . . . . 3.8100000000000001 111.436 177.07 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 N--CA 1.48 1.037 0 N-CA-C 109.341 -0.615 . . . . 13.17 109.341 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -93.67 -12.07 30.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.439 -0.346 . . . . 10.300000000000001 111.441 -170.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -91.6 81.8 5.32 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.949 0.404 . . . . 8.9100000000000001 110.204 177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 12.6 p -81.55 -24.6 36.47 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.722 -0.672 . . . . 7.79 111.111 -178.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.7 -175.59 28.28 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.661 -0.781 . . . . 5.0199999999999996 111.734 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 -67.23 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.748 -0.739 . . . . 3.1600000000000001 112.096 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.691 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 34.5 m -136.9 -115.8 0.17 Allowed 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.602 -0.518 . . . . 1.51 109.602 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' H ' ' HB2' ' A' ' 11' ' ' TYR . 17.2 t -86.85 165.88 2.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.878 -0.786 . . . . 0.81999999999999995 108.878 175.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -55.9 -38.94 70.88 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 120.921 0.391 . . . . 0.47999999999999998 110.947 176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -96.61 24.56 30.18 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.907 -0.588 . . . . 0.28000000000000003 111.981 176.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.681 ' HD2' ' HB2' ' A' ' 19' ' ' CYS . 25.9 m-85 -138.68 85.85 2.11 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.234 0.54 . . . . 0.53000000000000003 110.297 178.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.43 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 58.3 mtt -81.67 101.02 9.79 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.919 -0.582 . . . . 2.1400000000000001 110.149 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 46.2 ttp180 -58.67 129.34 41.65 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.241 0.543 . . . . 1.8999999999999999 111.226 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 49.6 p -80.64 160.09 67.8 Favored Pre-proline 0 C--N 1.315 -0.922 0 CA-C-N 115.606 -0.724 . . . . 0.41999999999999998 110.012 175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.03 -13.82 7.23 Favored 'Trans proline' 0 CA--C 1.533 0.453 0 C-N-CA 123.186 2.59 . . . . 0.67000000000000004 112.787 174.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -79.14 -47.35 16.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.02 -0.536 . . . . 1.95 110.555 175.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 138.07 -21.98 3.12 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.706 -0.759 . . . . 0.51000000000000001 112.77 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.436 HH11 ' HD2' ' A' ' 18' ' ' ARG . 15.7 ttp180 -78.15 137.42 38.18 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.781 -0.452 . . . . 3.0499999999999998 109.781 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.718 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 6.7 m -85.86 139.25 31.42 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 109.345 -0.613 . . . . 0.59999999999999998 109.345 -178.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.0 tptm -78.93 108.26 7.81 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 109.428 -0.582 . . . . 1.3799999999999999 109.428 177.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 62.1 Cg_endo -83.56 123.35 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.818 2.345 . . . . 0.58999999999999997 112.402 -173.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 73.4 p -88.57 78.7 7.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.34 0.59 . . . . 1.8 109.846 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 23.0 p90 . . . . . 0 C--O 1.242 0.684 0 CA-C-N 115.509 -0.769 . . . . 3.8100000000000001 110.617 -178.666 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.442 0.163 . . . . 13.17 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -99.78 -74.08 0.61 Allowed 'General case' 0 N--CA 1.461 0.115 0 CA-C-O 120.707 0.289 . . . . 10.300000000000001 111.647 -177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -91.32 23.43 3.37 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.371 0.605 . . . . 8.9100000000000001 111.031 -175.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.4 m -84.5 104.36 14.43 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.755 -0.657 . . . . 7.79 110.972 -177.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.96 -109.51 3.7 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.628 -0.796 . . . . 5.0199999999999996 112.104 -179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.98 151.5 7.42 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 121.163 -0.541 . . . . 3.1600000000000001 112.352 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.5 m -140.98 146.36 37.18 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.784 0.326 . . . . 1.51 110.61 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 9' ' ' ALA . 6.6 t -73.85 168.12 2.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.768 -0.651 . . . . 0.81999999999999995 110.042 -178.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.75 -27.43 64.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.47999999999999998 110.685 175.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.8 20.2 25.46 Favored Glycine 0 C--O 1.237 0.339 0 C-N-CA 121.184 -0.531 . . . . 0.28000000000000003 112.183 175.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.751 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 22.4 m-85 -133.96 90.3 2.68 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.281 0.562 . . . . 0.53000000000000003 109.949 176.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.515 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 25.0 mmt -81.37 101.82 10.07 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.657 -0.701 . . . . 2.1400000000000001 110.923 -176.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 5.2 ttp180 -66.39 117.04 8.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.995 0.426 . . . . 1.8999999999999999 110.113 178.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 60.8 p -83.51 167.81 26.29 Favored Pre-proline 0 C--N 1.311 -1.084 0 N-CA-C 109.581 -0.525 . . . . 0.41999999999999998 109.581 177.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.97 -11.65 7.85 Favored 'Trans proline' 0 CA--C 1.533 0.439 0 C-N-CA 123.208 2.605 . . . . 0.67000000000000004 112.603 171.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -79.26 -13.77 59.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.141 0.496 . . . . 1.95 109.726 176.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.03 6.74 78.69 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.366 -0.834 . . . . 0.51000000000000001 112.924 178.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 13' ' ' ARG . 34.0 ttm180 -101.01 150.04 23.31 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.889 -0.782 . . . . 3.0499999999999998 108.889 175.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.751 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 99.6 m -100.19 126.89 46.52 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 109.678 -0.49 . . . . 0.59999999999999998 109.678 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.669 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 51.8 tptt -76.03 109.51 8.46 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.832 -0.622 . . . . 1.3799999999999999 109.585 -176.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.669 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 75.3 Cg_endo -82.27 101.84 1.14 Allowed 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.99 2.46 . . . . 0.58999999999999997 112.87 -172.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.8 t -119.13 -18.65 8.65 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.859 -0.609 . . . . 1.8 110.445 176.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 . . . . . 0 C--O 1.246 0.919 0 CA-C-O 117.958 -1.02 . . . . 3.8100000000000001 110.801 -179.972 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 . . . . . 0 N--CA 1.482 1.169 0 CA-C-O 120.823 0.344 . . . . 13.17 110.742 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -120.3 -74.21 0.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.018 0.437 . . . . 10.300000000000001 110.386 -176.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -81.65 -23.4 36.96 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.923 -0.58 . . . . 8.9100000000000001 111.214 -175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.1 m -82.95 7.35 15.75 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.315 0.487 . . . . 7.79 112.315 -173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.573 ' HA2' ' H ' ' A' ' 13' ' ' ARG . . . -174.83 152.5 13.99 Favored Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.642 -1.266 . . . . 5.0199999999999996 112.934 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.15 37.64 1.31 Allowed Glycine 0 CA--C 1.507 -0.441 0 N-CA-C 109.882 -1.287 . . . . 3.1600000000000001 109.882 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' SG ' ' HB3' ' A' ' 11' ' ' TYR . 0.5 OUTLIER -160.08 -157.69 0.58 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.586 -0.807 . . . . 1.51 109.591 -172.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.708 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 8.0 t -62.25 160.55 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 120.455 0.169 . . . . 0.81999999999999995 110.69 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.65 -33.28 68.13 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.891 0.377 . . . . 0.47999999999999998 111.858 -179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.18 26.31 7.96 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.963 -0.637 . . . . 0.28000000000000003 112.145 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.962 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 48.3 m-85 -138.31 97.72 3.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.271 0.558 . . . . 0.53000000000000003 110.081 178.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.478 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 59.6 mtt -92.87 111.07 22.56 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.984 -0.553 . . . . 2.1400000000000001 110.331 -178.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.573 ' H ' ' HA2' ' A' ' 5' ' ' GLY . 55.2 ttp180 -63.8 128.58 36.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.097 0.475 . . . . 1.8999999999999999 111.044 -174.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 40.5 p -94.41 167.52 13.21 Favored Pre-proline 0 C--N 1.315 -0.91 0 CA-C-N 115.446 -0.797 . . . . 0.41999999999999998 110.09 178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -53.19 -18.75 10.84 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.192 2.595 . . . . 0.67000000000000004 113.201 171.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -78.58 -12.52 60.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 1.95 110.553 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 87.25 -10.47 68.8 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.689 -0.687 . . . . 0.51000000000000001 111.982 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 32.2 ttm180 -78.98 148.63 32.51 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.245 -0.65 . . . . 3.0499999999999998 109.245 177.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.962 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 84.6 m -89.15 130.27 35.61 Favored 'General case' 0 N--CA 1.439 -1.019 0 N-CA-C 109.013 -0.736 . . . . 0.59999999999999998 109.013 179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.1 tptt -77.5 107.41 5.13 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 109.101 -0.703 . . . . 1.3799999999999999 109.101 178.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HB3' ' CE1' ' A' ' 11' ' ' TYR . 46.6 Cg_endo -80.67 143.81 15.2 Favored 'Trans proline' 0 N--CA 1.445 -1.351 0 C-N-CA 122.23 1.953 . . . . 0.58999999999999997 110.636 -176.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 36.4 p -86.79 91.18 8.55 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.151 0.501 . . . . 1.8 111.754 -174.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.7 p90 . . . . . 0 C--O 1.244 0.798 0 CA-C-N 115.43 -0.805 . . . . 3.8100000000000001 109.261 174.618 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.471 0.177 . . . . 13.17 110.8 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -79.19 -53.92 6.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.252 -0.431 . . . . 10.300000000000001 110.606 -177.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -104.04 126.07 50.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.804 0.335 . . . . 8.9100000000000001 110.179 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.5 m -64.11 113.8 3.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.865 -0.607 . . . . 7.79 111.19 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -148.07 -178.85 23.57 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.908 -0.663 . . . . 5.0199999999999996 111.648 179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.48 -34.38 5.62 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.846 -0.692 . . . . 3.1600000000000001 111.817 177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 64.6 m -116.09 151.78 34.91 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.786 0.327 . . . . 1.51 110.744 179.241 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 9' ' ' ALA . 3.6 t -82.49 172.29 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.186 -0.461 . . . . 0.81999999999999995 109.857 -178.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.504 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -54.05 -37.85 64.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.807 0.337 . . . . 0.47999999999999998 110.658 175.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.92 19.63 9.44 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.85 -0.614 . . . . 0.28000000000000003 112.394 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.519 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 24.9 m-85 -133.26 90.77 2.78 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.831 0.348 . . . . 0.53000000000000003 110.265 176.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 86.2 mtp -90.14 106.21 18.33 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.64 -0.504 . . . . 2.1400000000000001 109.64 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.84 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 32.4 ptt180 -61.74 148.51 42.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.415 0.626 . . . . 1.8999999999999999 111.732 -176.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 29.5 p -106.9 161.96 21.21 Favored Pre-proline 0 C--N 1.317 -0.83 0 N-CA-C 109.006 -0.739 . . . . 0.41999999999999998 109.006 173.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.4 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.9 Cg_endo -56.49 -5.3 1.05 Allowed 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 123.156 2.571 . . . . 0.67000000000000004 113.289 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -78.8 -31.56 45.99 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.293 0.568 . . . . 1.95 109.536 175.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 109.04 -1.12 31.5 Favored Glycine 0 N--CA 1.442 -0.953 0 CA-C-N 115.666 -0.697 . . . . 0.51000000000000001 112.134 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -102.15 145.2 29.72 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.066 -0.716 . . . . 3.0499999999999998 109.066 174.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.84 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 91.7 m -95.79 142.62 27.84 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.972 0.415 . . . . 0.59999999999999998 110.754 -178.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 43.0 tptt -77.8 111.39 17.48 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 1.3799999999999999 109.165 178.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 93.1 Cg_endo -86.19 101.06 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.956 0 C-N-CA 122.959 2.44 . . . . 0.58999999999999997 113.192 -173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.8 t -118.25 88.53 2.94 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 122.046 0.927 . . . . 1.8 109.089 173.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 5.7 p90 . . . . . 0 C--O 1.246 0.894 0 CA-C-N 115.012 -0.994 . . . . 3.8100000000000001 110.936 -175.648 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 . . . . . 0 N--CA 1.476 0.834 0 CA-C-O 121.029 0.443 . . . . 13.17 110.432 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -95.58 83.85 3.85 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.469 -0.567 . . . . 10.300000000000001 109.469 175.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -124.02 136.62 54.4 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.099 -0.5 . . . . 8.9100000000000001 109.894 -177.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 7' ' ' CYS . 8.8 m -74.09 -16.3 61.03 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.128 -0.487 . . . . 7.79 111.809 -175.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.2 -122.6 6.51 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.697 -0.763 . . . . 5.0199999999999996 113.125 174.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -76.98 -11.18 85.8 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.358 -0.449 . . . . 3.1600000000000001 112.921 -176.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.705 ' SG ' ' HB3' ' A' ' 13' ' ' ARG . 58.4 m -116.94 154.27 31.14 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.639 -0.504 . . . . 1.51 109.639 178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 9' ' ' ALA . 5.9 t -78.39 169.76 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 110.083 -0.34 . . . . 0.81999999999999995 110.083 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -59.03 -32.3 69.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.895 0.378 . . . . 0.47999999999999998 110.285 174.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.64 22.46 27.67 Favored Glycine 0 C--N 1.332 0.345 0 N-CA-C 111.554 -0.618 . . . . 0.28000000000000003 111.554 176.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.589 ' HA ' ' O ' ' A' ' 20' ' ' LYS . 14.5 m-85 -141.66 82.78 1.83 Allowed 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 122.794 0.438 . . . . 0.53000000000000003 110.495 178.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 91.9 mmm -81.85 102.42 10.83 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.79 -0.448 . . . . 2.1400000000000001 109.79 179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 1.119 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 29.2 ptt180 -63.71 156.26 27.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.36 0.6 . . . . 1.8999999999999999 112.302 -170.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.438 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 28.3 p -119.8 161.53 37.53 Favored Pre-proline 0 N--CA 1.443 -0.793 0 CA-C-N 115.023 -0.989 . . . . 0.41999999999999998 109.924 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.438 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 13.6 Cg_endo -61.58 0.26 1.17 Allowed 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.163 2.575 . . . . 0.67000000000000004 113.091 174.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -78.57 -29.46 46.26 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 108.52 -0.919 . . . . 1.95 108.52 172.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 112.23 -10.78 26.66 Favored Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 114.834 -1.076 . . . . 0.51000000000000001 112.319 178.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.5 ptt180 -90.26 176.93 6.56 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.342 -0.614 . . . . 3.0499999999999998 109.342 173.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 1.119 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 2.4 m -113.93 142.65 45.86 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.953 -1.129 . . . . 0.59999999999999998 107.953 174.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.672 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 47.1 tptt -77.46 113.04 28.06 Favored Pre-proline 0 C--N 1.329 -0.302 0 N-CA-C 109.714 -0.476 . . . . 1.3799999999999999 109.714 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.672 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 95.8 Cg_endo -78.03 107.79 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 122.745 2.296 . . . . 0.58999999999999997 111.399 -178.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.4 p -88.94 -31.59 18.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.8 -0.636 . . . . 1.8 110.465 -176.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 117.778 -1.105 . . . . 3.8100000000000001 110.103 -174.543 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.083 0.468 . . . . 13.17 110.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 8.7 m-20 -83.55 104.58 13.79 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.317 0.579 . . . . 10.300000000000001 110.021 177.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 44.9 p90 -79.4 -1.07 35.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.484 -0.78 . . . . 8.9100000000000001 111.18 -176.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 9.5 t -71.15 -30.38 66.38 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.089 -0.505 . . . . 7.79 110.019 176.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -172.93 126.88 1.29 Allowed Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 121.091 -0.576 . . . . 5.0199999999999996 111.718 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.28 56.08 1.75 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.953 -0.641 . . . . 3.1600000000000001 112.486 -176.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 15.8 m -139.58 159.34 42.39 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.897 0.379 . . . . 1.51 110.603 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 8' ' ' VAL . 3.3 t -65.45 163.82 2.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.663 -0.699 . . . . 0.81999999999999995 110.569 -179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.62 -29.1 64.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.009 0.433 . . . . 0.47999999999999998 110.187 171.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 23' ' ' PHE . . . -91.95 26.48 12.76 Favored Glycine 0 C--O 1.226 -0.352 0 CA-C-N 115.571 -0.74 . . . . 0.28000000000000003 111.906 175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 14.2 m-85 -143.35 91.28 2.25 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.459 -0.571 . . . . 0.53000000000000003 109.459 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.6 mtm -90.35 109.71 20.81 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.634 -0.712 . . . . 2.1400000000000001 110.087 -175.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 52.8 ttp180 -55.62 131.1 45.54 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 121.311 0.577 . . . . 1.8999999999999999 111.444 -174.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 74.1 p -93.57 162.11 28.55 Favored Pre-proline 0 N--CA 1.442 -0.851 0 CA-C-N 115.327 -0.851 . . . . 0.41999999999999998 110.048 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -45.24 -25.98 2.2 Favored 'Trans proline' 0 CA--C 1.535 0.527 0 C-N-CA 123.706 2.937 . . . . 0.67000000000000004 113.792 173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.4 m-20 -78.62 -21.27 48.71 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.966 0.412 . . . . 1.95 111.101 -178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 102.13 -4.47 52.18 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.208 -0.52 . . . . 0.51000000000000001 111.841 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.584 ' HG2' ' H ' ' A' ' 19' ' ' CYS . 37.5 ttm180 -82.0 179.81 7.68 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.197 -1.408 . . . . 3.0499999999999998 107.197 170.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.606 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 85.6 m -122.09 139.38 53.79 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.026 -0.669 . . . . 0.59999999999999998 109.328 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.659 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 24.7 tptp -75.46 112.82 20.97 Favored Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.834 -0.802 . . . . 1.3799999999999999 108.834 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.659 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 72.7 Cg_endo -69.75 98.17 0.67 Allowed 'Trans proline' 0 N--CA 1.451 -0.971 0 C-N-CA 122.722 2.282 . . . . 0.58999999999999997 110.941 -175.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 7.4 m -107.12 -23.13 12.4 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.122 -1.399 . . . . 1.8 109.503 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.447 ' O ' ' HA3' ' A' ' 10' ' ' GLY . 56.2 m-85 . . . . . 0 C--O 1.248 0.997 0 CA-C-N 114.936 -1.029 . . . . 3.8100000000000001 111.02 174.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.867 -0.049 . . . . 13.17 110.867 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -149.58 -59.86 0.21 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.218 0.451 . . . . 10.300000000000001 112.218 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -107.61 14.07 26.06 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.28 0.474 . . . . 8.9100000000000001 112.28 -168.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 21.5 t -77.07 -22.97 52.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.61 0.243 . . . . 7.79 111.142 -177.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -151.57 -140.99 3.25 Favored Glycine 0 CA--C 1.52 0.384 0 C-N-CA 120.771 -0.728 . . . . 5.0199999999999996 112.401 -178.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 139.88 -35.03 1.96 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.842 -0.694 . . . . 3.1600000000000001 112.218 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.61 ' SG ' ' HB2' ' A' ' 13' ' ' ARG . 18.4 m -121.18 -160.97 0.88 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.998 0.428 . . . . 1.51 110.639 -177.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 9' ' ' ALA . 11.9 t -88.86 167.48 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.546 . . . . 0.81999999999999995 109.764 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.8 -46.44 81.59 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.845 0.355 . . . . 0.47999999999999998 111.287 177.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.97 23.57 10.55 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.178 -0.534 . . . . 0.28000000000000003 111.84 176.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.676 ' CE2' ' HB3' ' A' ' 21' ' ' PRO . 17.5 m-85 -134.86 80.51 1.85 Allowed 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.013 0.435 . . . . 0.53000000000000003 110.032 177.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 62.3 mtt -80.02 104.35 10.53 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 110.134 -176.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 53.1 ttp180 -61.77 123.72 18.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.934 0.397 . . . . 1.8999999999999999 110.574 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 79.0 p -84.59 166.07 34.46 Favored Pre-proline 0 C--N 1.314 -0.947 0 CA-C-N 115.772 -0.649 . . . . 0.41999999999999998 110.283 177.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -53.69 -14.89 5.81 Favored 'Trans proline' 0 CA--C 1.535 0.549 0 C-N-CA 122.837 2.358 . . . . 0.67000000000000004 112.641 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -78.49 -27.38 46.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.391 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.58 -4.79 37.24 Favored Glycine 0 N--CA 1.448 -0.513 0 CA-C-N 115.762 -0.654 . . . . 0.51000000000000001 111.923 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 43.3 ttm180 -89.61 143.67 26.62 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.22 -0.659 . . . . 3.0499999999999998 109.22 176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.658 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 6.2 m -90.13 127.66 36.15 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.336 -0.987 . . . . 0.59999999999999998 108.336 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.521 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 24.4 tptm -77.28 109.46 9.36 Favored Pre-proline 0 CA--C 1.516 -0.344 0 N-CA-C 109.703 -0.48 . . . . 1.3799999999999999 109.703 -176.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.676 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 61.8 Cg_endo -87.73 96.81 0.43 Allowed 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 123.046 2.497 . . . . 0.58999999999999997 112.769 -172.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 5.0 t -98.93 94.08 6.37 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.732 0.777 . . . . 1.8 110.036 177.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 11.0 p90 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.297 -0.858 . . . . 3.8100000000000001 110.703 -178.331 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 109.988 -0.375 . . . . 13.17 109.988 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -96.67 -60.77 1.53 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.681 -0.489 . . . . 10.300000000000001 109.681 178.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -97.88 115.05 27.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.942 -0.572 . . . . 8.9100000000000001 109.907 176.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 8.7 p -90.37 -67.22 0.86 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.211 0.529 . . . . 7.79 110.552 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.52 110.11 0.43 Allowed Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.686 -0.688 . . . . 5.0199999999999996 111.928 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -66.37 -30.83 77.33 Favored Glycine 0 CA--C 1.51 -0.243 0 C-N-CA 120.666 -0.778 . . . . 3.1600000000000001 112.325 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 10.1 m -142.52 162.05 36.47 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.659 0.266 . . . . 1.51 110.542 177.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 9' ' ' ALA . 2.8 t -71.63 168.55 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 CA-C-N 115.755 -0.657 . . . . 0.81999999999999995 111.152 -176.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.402 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -56.87 -37.4 71.28 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.944 0.402 . . . . 0.47999999999999998 110.779 174.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.38 15.99 51.34 Favored Glycine 0 N--CA 1.454 -0.139 0 C-N-CA 121.155 -0.545 . . . . 0.28000000000000003 111.952 176.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 7' ' ' CYS . 7.3 m-85 -131.23 82.17 2.03 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.475 -0.565 . . . . 0.53000000000000003 109.475 175.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 95.7 mmm -89.7 107.68 19.24 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.334 -0.394 . . . . 2.1400000000000001 110.48 -176.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.68 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ptm180 -64.31 128.11 34.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.135 -0.484 . . . . 1.8999999999999999 111.066 179.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.594 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 52.9 p -83.7 167.31 29.11 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.571 -0.741 . . . . 0.41999999999999998 109.638 175.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 12.5 Cg_endo -58.96 -9.82 8.61 Favored 'Trans proline' 0 CA--C 1.533 0.462 0 C-N-CA 122.91 2.406 . . . . 0.67000000000000004 112.664 174.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -79.9 -26.17 40.32 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.104 0.478 . . . . 1.95 109.741 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 103.89 2.71 45.91 Favored Glycine 0 CA--C 1.518 0.269 0 CA-C-N 115.808 -0.633 . . . . 0.51000000000000001 112.314 -178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 15.9 tpp180 -97.12 137.38 36.26 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.169 -0.678 . . . . 3.0499999999999998 109.169 177.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.68 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 89.5 m -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.132 -0.627 . . . . 0.59999999999999998 109.35 -179.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 38.4 tptt -76.66 111.64 17.16 Favored Pre-proline 0 N--CA 1.451 -0.412 0 N-CA-C 109.1 -0.704 . . . . 1.3799999999999999 109.1 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.606 ' HB3' ' CE2' ' A' ' 11' ' ' TYR . 49.5 Cg_endo -90.57 93.91 0.26 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 123.236 2.624 . . . . 0.58999999999999997 112.725 -173.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.0 t -110.21 -7.79 14.83 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.763 -0.653 . . . . 1.8 110.148 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.372 -0.831 . . . . 3.8100000000000001 111.444 177.708 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 . . . . . 0 N--CA 1.483 1.184 0 CA-C-O 121.032 0.444 . . . . 13.17 110.435 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -101.15 103.98 15.06 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.253 -0.431 . . . . 10.300000000000001 110.093 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -97.23 -25.44 15.28 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.063 0.458 . . . . 8.9100000000000001 110.776 -178.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 t -81.56 13.4 3.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.256 -0.429 . . . . 7.79 111.53 -175.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -77.1 -24.94 65.16 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.719 -0.753 . . . . 5.0199999999999996 112.452 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 179.31 -174.68 46.53 Favored Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 111.159 -0.776 . . . . 3.1600000000000001 111.159 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.55 165.87 25.76 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.696 0.284 . . . . 1.51 110.625 -178.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.723 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 14.3 t -73.72 165.51 3.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.27 -0.423 . . . . 0.81999999999999995 110.216 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.427 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -58.4 -31.52 67.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.739 0.304 . . . . 0.47999999999999998 111.494 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.87 25.2 17.48 Favored Glycine 0 CA--C 1.51 -0.256 0 C-N-CA 121.123 -0.56 . . . . 0.28000000000000003 111.839 177.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.723 ' HD2' ' HB ' ' A' ' 8' ' ' VAL . 40.5 m-85 -135.41 97.34 3.67 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.099 0.475 . . . . 0.53000000000000003 111.077 178.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 16.3 mmt -90.6 102.84 15.58 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.056 -0.52 . . . . 2.1400000000000001 110.24 177.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.724 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 55.5 ttp180 -61.89 136.4 57.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.376 0.607 . . . . 1.8999999999999999 111.182 -176.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 72.1 p -96.73 164.81 17.27 Favored Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 114.975 -1.011 . . . . 0.41999999999999998 109.637 174.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.51 -13.54 10.74 Favored 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.735 2.29 . . . . 0.67000000000000004 112.723 172.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -80.18 -16.21 55.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.23 0.538 . . . . 1.95 110.405 177.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 100.75 -21.21 44.78 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.575 -0.738 . . . . 0.51000000000000001 112.844 176.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -86.16 146.83 26.4 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.508 -0.553 . . . . 3.0499999999999998 109.508 176.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.724 ' HA ' ' HA ' ' A' ' 13' ' ' ARG . 74.5 m -95.29 145.66 24.92 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.729 -0.471 . . . . 0.59999999999999998 109.729 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.632 ' HD2' ' HD2' ' A' ' 21' ' ' PRO . 26.7 tptp -78.23 111.78 21.07 Favored Pre-proline 0 C--N 1.32 -0.709 0 N-CA-C 109.437 -0.579 . . . . 1.3799999999999999 109.437 176.378 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.632 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 94.8 Cg_endo -79.65 106.42 1.98 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.329 2.02 . . . . 0.58999999999999997 110.926 179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.0 t -97.11 97.94 9.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.902 0.858 . . . . 1.8 111.172 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.4 p90 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.686 -1.143 . . . . 3.8100000000000001 108.857 173.174 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 N--CA 1.481 1.112 0 N-CA-C 111.866 0.321 . . . . 13.17 111.866 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -107.94 152.97 23.73 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.797 -0.445 . . . . 10.300000000000001 109.797 177.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -125.7 -40.91 2.03 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.824 0.345 . . . . 8.9100000000000001 111.341 -175.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.4 t -71.47 121.18 18.17 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.833 -0.347 . . . . 7.79 110.811 -175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 165.31 85.32 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.027 -0.606 . . . . 5.0199999999999996 112.578 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 162.77 146.47 4.7 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.578 -0.82 . . . . 3.1600000000000001 112.446 176.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 p -149.24 -175.53 5.02 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.028 -0.36 . . . . 1.51 110.028 174.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.737 ' HB ' ' HD2' ' A' ' 11' ' ' TYR . 21.6 t -59.62 154.39 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 122.509 0.323 . . . . 0.81999999999999995 111.214 -177.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -56.08 -31.67 63.43 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.44 -0.346 . . . . 0.47999999999999998 111.461 177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -89.04 26.0 9.23 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 121.096 -0.573 . . . . 0.28000000000000003 112.18 176.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.76 ' HB3' ' HB3' ' A' ' 19' ' ' CYS . 36.4 m-85 -138.71 102.85 4.69 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 123.031 0.532 . . . . 0.53000000000000003 109.744 176.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 65.2 mtt -93.41 106.31 18.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.077 -0.342 . . . . 2.1400000000000001 110.077 178.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.9 ttt85 -56.14 136.42 52.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 1.8999999999999999 111.974 -176.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.463 ' HB ' ' HD2' ' A' ' 15' ' ' PRO . 67.7 p -95.53 163.47 21.38 Favored Pre-proline 0 N--CA 1.445 -0.68 0 CA-C-N 115.143 -0.935 . . . . 0.41999999999999998 109.565 173.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 14' ' ' THR . 9.7 Cg_endo -55.2 -19.37 20.86 Favored 'Trans proline' 0 CA--C 1.532 0.379 0 C-N-CA 123.105 2.537 . . . . 0.67000000000000004 112.726 174.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -78.29 -19.71 53.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.089 0.471 . . . . 1.95 110.322 178.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 13' ' ' ARG . . . 107.34 -22.26 29.31 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.858 -0.61 . . . . 0.51000000000000001 112.568 178.508 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.1 ttp85 -78.63 143.47 36.34 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.793 -0.818 . . . . 3.0499999999999998 108.793 177.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.76 ' HB3' ' HB3' ' A' ' 11' ' ' TYR . 76.7 m -97.37 147.92 23.69 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.42 -0.585 . . . . 0.59999999999999998 109.42 -175.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 21.9 tptm -77.32 111.19 15.39 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 116.344 -0.389 . . . . 1.3799999999999999 110.064 -178.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.625 ' HD2' ' HD2' ' A' ' 20' ' ' LYS . 91.6 Cg_endo -75.79 97.04 1.08 Allowed 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.594 2.196 . . . . 0.58999999999999997 110.922 -178.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.5 t -125.21 21.51 8.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.678 -0.692 . . . . 1.8 110.27 -174.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 35.8 p90 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.302 -0.856 . . . . 3.8100000000000001 110.879 178.331 . . . . . . . . 0 0 . 1 stop_ save_